US20190264216A1 - Fungal artificial chromosomes, compositions, methods and uses therefor - Google Patents
Fungal artificial chromosomes, compositions, methods and uses therefor Download PDFInfo
- Publication number
- US20190264216A1 US20190264216A1 US16/409,586 US201916409586A US2019264216A1 US 20190264216 A1 US20190264216 A1 US 20190264216A1 US 201916409586 A US201916409586 A US 201916409586A US 2019264216 A1 US2019264216 A1 US 2019264216A1
- Authority
- US
- United States
- Prior art keywords
- fungal
- fac
- gene
- artificial chromosome
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002538 fungal effect Effects 0.000 title claims abstract description 142
- 210000004507 artificial chromosome Anatomy 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title abstract description 46
- 239000000203 mixture Substances 0.000 title description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 83
- 230000001580 bacterial effect Effects 0.000 claims abstract description 44
- 239000003550 marker Substances 0.000 claims abstract description 44
- 230000010076 replication Effects 0.000 claims abstract description 32
- 239000013612 plasmid Substances 0.000 claims abstract description 29
- 210000004436 artificial bacterial chromosome Anatomy 0.000 claims description 46
- 241000588724 Escherichia coli Species 0.000 claims description 36
- 230000001939 inductive effect Effects 0.000 claims description 25
- 241000228212 Aspergillus Species 0.000 claims description 17
- 230000010354 integration Effects 0.000 claims description 15
- 108091008146 restriction endonucleases Proteins 0.000 claims description 15
- 230000029087 digestion Effects 0.000 claims description 13
- 108010061833 Integrases Proteins 0.000 claims description 12
- 230000000295 complement effect Effects 0.000 claims description 12
- 101150016309 trpC gene Proteins 0.000 claims description 10
- 101100370749 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) trpC1 gene Proteins 0.000 claims description 9
- 230000003362 replicative effect Effects 0.000 claims description 9
- 101150078331 ama-1 gene Proteins 0.000 claims description 7
- 229940037201 oris Drugs 0.000 claims description 7
- 229960005091 chloramphenicol Drugs 0.000 claims description 6
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims description 6
- 101150054232 pyrG gene Proteins 0.000 claims description 6
- 101150045500 galK gene Proteins 0.000 claims description 4
- 101100425074 Aspergillus oryzae (strain ATCC 42149 / RIB 40) thiA gene Proteins 0.000 claims description 3
- 101150060364 ptrA gene Proteins 0.000 claims description 3
- 101100455492 Escherichia coli (strain K12) lrhA gene Proteins 0.000 claims description 2
- 101150073130 ampR gene Proteins 0.000 claims description 2
- 229930000044 secondary metabolite Natural products 0.000 abstract description 116
- 239000013598 vector Substances 0.000 abstract description 116
- 108091008053 gene clusters Proteins 0.000 abstract description 76
- 238000010367 cloning Methods 0.000 abstract description 36
- 230000006801 homologous recombination Effects 0.000 abstract description 8
- 238000002744 homologous recombination Methods 0.000 abstract description 8
- 230000009977 dual effect Effects 0.000 abstract description 3
- 108020004414 DNA Proteins 0.000 description 140
- 241000351920 Aspergillus nidulans Species 0.000 description 56
- 241000233866 Fungi Species 0.000 description 32
- 239000012634 fragment Substances 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 23
- 230000014509 gene expression Effects 0.000 description 19
- 241000228260 Aspergillus wentii Species 0.000 description 16
- 102100027286 Fanconi anemia group C protein Human genes 0.000 description 16
- 230000037361 pathway Effects 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000003780 insertion Methods 0.000 description 15
- 230000037431 insertion Effects 0.000 description 15
- 239000000872 buffer Substances 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 14
- 210000001938 protoplast Anatomy 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 238000013459 approach Methods 0.000 description 11
- 238000010276 construction Methods 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 241000894007 species Species 0.000 description 11
- 238000012217 deletion Methods 0.000 description 10
- 230000037430 deletion Effects 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- 238000012986 modification Methods 0.000 description 10
- 230000004048 modification Effects 0.000 description 10
- 229930014626 natural product Natural products 0.000 description 10
- 230000001105 regulatory effect Effects 0.000 description 10
- 241001465318 Aspergillus terreus Species 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 241001136782 Alca Species 0.000 description 8
- 108020005091 Replication Origin Proteins 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 238000012423 maintenance Methods 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- 229920000936 Agarose Polymers 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 230000001851 biosynthetic effect Effects 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 101000979117 Curvularia clavata Nonribosomal peptide synthetase Proteins 0.000 description 6
- 241000206602 Eukaryota Species 0.000 description 6
- 102000048120 Galactokinases Human genes 0.000 description 6
- 108700023157 Galactokinases Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000004927 fusion Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 239000013605 shuttle vector Substances 0.000 description 6
- 241000228230 Aspergillus parasiticus Species 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 108020000949 Fungal DNA Proteins 0.000 description 5
- 101710088839 Replication initiation protein Proteins 0.000 description 5
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 210000004940 nucleus Anatomy 0.000 description 5
- 238000004885 tandem mass spectrometry Methods 0.000 description 5
- -1 without limitation Proteins 0.000 description 5
- 241000228215 Aspergillus aculeatus Species 0.000 description 4
- 241001225321 Aspergillus fumigatus Species 0.000 description 4
- 241000374462 Aspergillus pseudoglaucus Species 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 108090000364 Ligases Proteins 0.000 description 4
- 102000003960 Ligases Human genes 0.000 description 4
- 108091023040 Transcription factor Proteins 0.000 description 4
- 102000040945 Transcription factor Human genes 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 229930191284 benzomalvin Natural products 0.000 description 4
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 4
- 101150073906 gpdA gene Proteins 0.000 description 4
- 101150095733 gpsA gene Proteins 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000000401 methanolic extract Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 238000010008 shearing Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000914343 Aspergillus ruber Species 0.000 description 3
- 241001607706 Aspergillus stellatus Species 0.000 description 3
- 241000193755 Bacillus cereus Species 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000427940 Fusarium solani Species 0.000 description 3
- 101150108358 GLAA gene Proteins 0.000 description 3
- 101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 3
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 241001123663 Penicillium expansum Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 241001523006 Talaromyces marneffei Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 101150008194 argB gene Proteins 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 101150039489 lysZ gene Proteins 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 229930001119 polyketide Natural products 0.000 description 3
- 150000003881 polyketide derivatives Chemical class 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- 101710135150 (+)-T-muurolol synthase ((2E,6E)-farnesyl diphosphate cyclizing) Proteins 0.000 description 2
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 2
- IHJVJWQYVQWURS-LRDDRELGSA-N (3s,6s)-3-methyl-6-[[7-(3-methylbut-2-enyl)-1h-indol-3-yl]methyl]piperazine-2,5-dione Chemical compound N1C(=O)[C@H](C)NC(=O)[C@@H]1CC1=CNC2=C(CC=C(C)C)C=CC=C12 IHJVJWQYVQWURS-LRDDRELGSA-N 0.000 description 2
- YYWUABJYAOCACI-NRFANRHFSA-N (7S)-7-benzyl-6-methyl-7H-quinazolino[3,2-a][1,4]benzodiazepine-5,13-dione Chemical compound C([C@@H]1N(C(C2=CC=CC=C2N2C(=O)C3=CC=CC=C3N=C21)=O)C)C1=CC=CC=C1 YYWUABJYAOCACI-NRFANRHFSA-N 0.000 description 2
- BMYCCWYAFNPAQC-UHFFFAOYSA-N 2-[dodecyl(methyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCN(C)CC(O)=O BMYCCWYAFNPAQC-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 241000183224 Actinoplanes ferrugineus Species 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 240000007068 Agaricus silvaticus Species 0.000 description 2
- 240000006421 Amaranthus dubius Species 0.000 description 2
- 241000228218 Aspergillus amstelodami Species 0.000 description 2
- 241001513093 Aspergillus awamori Species 0.000 description 2
- 241000125121 Aspergillus carbonarius Species 0.000 description 2
- 241000750530 Aspergillus cavernicola Species 0.000 description 2
- 241001065417 Aspergillus chevalieri Species 0.000 description 2
- 241001507865 Aspergillus fischeri Species 0.000 description 2
- 241001084805 Aspergillus fruticulosus Species 0.000 description 2
- 241000132177 Aspergillus glaucus Species 0.000 description 2
- 241000981399 Aspergillus melleus Species 0.000 description 2
- 241000132181 Aspergillus niveoglaucus Species 0.000 description 2
- 241000750573 Aspergillus peyronelii Species 0.000 description 2
- 241000228251 Aspergillus phoenicis Species 0.000 description 2
- 241000131370 Aspergillus quadricinctus Species 0.000 description 2
- 241001084792 Aspergillus roseoglobulosus Species 0.000 description 2
- 241001199513 Aspergillus striatus Species 0.000 description 2
- 241000981365 Aspergillus sulphureus Species 0.000 description 2
- 241000203233 Aspergillus versicolor Species 0.000 description 2
- 241000133689 Aspergillus violaceus Species 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 101710119400 Geranylfarnesyl diphosphate synthase Proteins 0.000 description 2
- 101710107752 Geranylgeranyl diphosphate synthase Proteins 0.000 description 2
- 244000153234 Hibiscus abelmoschus Species 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108700005443 Microbial Genes Proteins 0.000 description 2
- 241000191938 Micrococcus luteus Species 0.000 description 2
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108010030975 Polyketide Synthases Proteins 0.000 description 2
- 102000018120 Recombinases Human genes 0.000 description 2
- 108010091086 Recombinases Proteins 0.000 description 2
- 108010019477 S-adenosyl-L-methionine-dependent N-methyltransferase Proteins 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- IHJVJWQYVQWURS-UHFFFAOYSA-N Terezine D Natural products CC1NC(=O)C(Cc2c[nH]c3c(CC=C(C)C)cccc23)NC1=O IHJVJWQYVQWURS-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 210000002230 centromere Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 229930000226 fungal secondary metabolite Natural products 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 238000012224 gene deletion Methods 0.000 description 2
- QRPYQNLMWIGUCP-VMBSUALFSA-N hexadehydroastechrome Chemical compound C1=CC=C2C(CC3=C(OC)N=C(C)C=4N3O[Fe-3]35([O+]=4)(ON4C(CC=6C7=CC=CC(\C=C\C(C)=C)=C7NC=6)=C(N=C(C)C4=[O+]3)OC)[O+]=C3N(C(=C(OC)N=C3C)CC=3C4=CC=CC(\C=C\C(C)=C)=C4NC=3)O5)=CNC2=C1\C=C\C(C)=C QRPYQNLMWIGUCP-VMBSUALFSA-N 0.000 description 2
- 238000007625 higher-energy collisional dissociation Methods 0.000 description 2
- 102000006639 indoleamine 2,3-dioxygenase Human genes 0.000 description 2
- 108020004201 indoleamine 2,3-dioxygenase Proteins 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 2
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000006151 minimal media Substances 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 108010000785 non-ribosomal peptide synthase Proteins 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 210000004215 spore Anatomy 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 102000055501 telomere Human genes 0.000 description 2
- 108091035539 telomere Proteins 0.000 description 2
- 210000003411 telomere Anatomy 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 108020002120 tryptophan dimethylallyltransferase Proteins 0.000 description 2
- 108700026220 vif Genes Proteins 0.000 description 2
- LUBKKVGXMXTXOZ-QGZVFWFLSA-N (+)-geodin Chemical compound COC(=O)C1=CC(=O)C=C(OC)[C@@]11C(=O)C(C(O)=C(Cl)C(C)=C2Cl)=C2O1 LUBKKVGXMXTXOZ-QGZVFWFLSA-N 0.000 description 1
- COXWNIZQNAMTQL-NQERJWCQSA-N (1'R,3R,12'R)-12'-methylspiro[1H-indole-3,16'-2,10,13-triazatetracyclo[10.2.2.02,11.04,9]hexadeca-4,6,8,10-tetraene]-2,3',14'-trione Chemical compound C12=NC3=CC=CC=C3C(=O)N1[C@H]1C(=O)N[C@]2(C)[C@]2(C3=CC=CC=C3NC2=O)C1 COXWNIZQNAMTQL-NQERJWCQSA-N 0.000 description 1
- LOUPRKONTZGTKE-VOMFEXJBSA-N (r)-[(2s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol Chemical compound C1C([C@H](C2)C=C)CCN2[C@@H]1[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-VOMFEXJBSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- VRYALKFFQXWPIH-HSUXUTPPSA-N 2-deoxy-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-HSUXUTPPSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- GZVCWRAFPVCGPA-BPGUCPLFSA-N 7-[(r)-hydroxy(phenyl)methyl]-6-methyl-7h-quinazolino[3,2-a][1,4]benzodiazepine-5,13-dione Chemical compound C1([C@@H](O)C2N(C(C3=CC=CC=C3N3C(=O)C4=CC=CC=C4N=C32)=O)C)=CC=CC=C1 GZVCWRAFPVCGPA-BPGUCPLFSA-N 0.000 description 1
- 240000006452 Abelmoschus crinitus Species 0.000 description 1
- 240000004507 Abelmoschus esculentus Species 0.000 description 1
- 241001674466 Abraeus globosus Species 0.000 description 1
- 240000000321 Abutilon grandifolium Species 0.000 description 1
- 241000299354 Acalles micros Species 0.000 description 1
- 241000692012 Acanthurus olivaceus Species 0.000 description 1
- 241000474244 Acaulospora rehmii Species 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 244000001632 Acorus gramineus Species 0.000 description 1
- 241001121497 Acrobeloides nanus Species 0.000 description 1
- 244000143294 Acrocephalus indicus Species 0.000 description 1
- 241000606801 Actinobacillus lignieresii Species 0.000 description 1
- 240000005007 Actinomucor elegans Species 0.000 description 1
- 241000187841 Actinoplanes digitatis Species 0.000 description 1
- 241000530580 Actinoplanes penicillatus Species 0.000 description 1
- 244000103594 Adenoncos virens Species 0.000 description 1
- 241001281904 Afrixalus delicatus Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 240000007440 Agaricus campestris Species 0.000 description 1
- 241001072675 Agaricus macrosporus Species 0.000 description 1
- 240000007792 Aglaia odoratissima Species 0.000 description 1
- 244000067632 Aglaonema simplex Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241000699657 Akodon subfuscus Species 0.000 description 1
- 244000126822 Albuca minor Species 0.000 description 1
- 241000303083 Algoriphagus halophilus Species 0.000 description 1
- 241000151534 Alkalibacillus flavidus Species 0.000 description 1
- 241000189415 Alopecurus aequalis Species 0.000 description 1
- 241001072835 Alophoixus phaeocephalus Species 0.000 description 1
- 241001105199 Amanita nigrescens Species 0.000 description 1
- 240000003147 Amaranthus hypochondriacus Species 0.000 description 1
- 240000003939 Amaranthus quitensis Species 0.000 description 1
- 241000207283 Amorphophallus fuscus Species 0.000 description 1
- 241000207236 Amorphophallus maximus Species 0.000 description 1
- 240000007304 Amorphophallus muelleri Species 0.000 description 1
- 240000004904 Amorphophallus paeoniifolius Species 0.000 description 1
- 241000351407 Amphibalanus variegatus Species 0.000 description 1
- 241000202839 Amycolatopsis sacchari Species 0.000 description 1
- 241000986600 Anablepsoides igneus Species 0.000 description 1
- 240000001518 Anchusa capensis Species 0.000 description 1
- 241000009428 Andricus crystallinus Species 0.000 description 1
- 240000001810 Angelica gigas Species 0.000 description 1
- 241001593781 Anisacanthus quadrifidus Species 0.000 description 1
- 241000511519 Ankistrodesmus densus Species 0.000 description 1
- 244000030795 Annona lutescens Species 0.000 description 1
- 244000099496 Anoectochilus flavescens Species 0.000 description 1
- 241000026897 Anorrhinus galeritus Species 0.000 description 1
- 241000226801 Antarctoscyphus spiralis Species 0.000 description 1
- 241001233851 Aphelocheirus ellipsoideus Species 0.000 description 1
- 241000653807 Aphistogoniulus erythrocephalus Species 0.000 description 1
- 241001229872 Aphodius fimetarius Species 0.000 description 1
- 240000000940 Araucaria angustifolia Species 0.000 description 1
- 241001234067 Argyrodes zonatus Species 0.000 description 1
- 241000692821 Arion intermedius Species 0.000 description 1
- 241001449166 Ariosoma scheelei Species 0.000 description 1
- 241000941939 Artabotrys velutinus Species 0.000 description 1
- 241000682743 Arthrobacter humicola Species 0.000 description 1
- 241000185993 Arthrobacter ramosus Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000122250 Artibeus obscurus Species 0.000 description 1
- 240000000852 Artocarpus odoratissimus Species 0.000 description 1
- 241000212115 Artomyces microsporus Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000605558 Asparagus maritimus Species 0.000 description 1
- 241000131299 Aspergillago clavatoflava Species 0.000 description 1
- 241001642196 Aspergillus acidus Species 0.000 description 1
- 241000272370 Aspergillus aculeatinus Species 0.000 description 1
- 241000133621 Aspergillus aeneus Species 0.000 description 1
- 241000245601 Aspergillus alabamensis Species 0.000 description 1
- 241001261360 Aspergillus alliaceus Species 0.000 description 1
- 241000071756 Aspergillus amazonicus Species 0.000 description 1
- 241000750553 Aspergillus ambiguus Species 0.000 description 1
- 241001626693 Aspergillus amoenus Species 0.000 description 1
- 241001178532 Aspergillus amyloliquefaciens Species 0.000 description 1
- 241000750537 Aspergillus amylovorus Species 0.000 description 1
- 241000789187 Aspergillus anomalus Species 0.000 description 1
- 241001503010 Aspergillus anthodesmis Species 0.000 description 1
- 241001579048 Aspergillus apicalis Species 0.000 description 1
- 241001011562 Aspergillus appendiculatus Species 0.000 description 1
- 241000241143 Aspergillus arachidicola Species 0.000 description 1
- 241001502779 Aspergillus arvii Species 0.000 description 1
- 241000750542 Aspergillus asperescens Species 0.000 description 1
- 241000772833 Aspergillus assulatus Species 0.000 description 1
- 241001161142 Aspergillus astellatus Species 0.000 description 1
- 241000133660 Aspergillus aurantiobrunneus Species 0.000 description 1
- 241000133626 Aspergillus aureolatus Species 0.000 description 1
- 241000131967 Aspergillus aureoterreus Species 0.000 description 1
- 241000981384 Aspergillus auricomus Species 0.000 description 1
- 241001084775 Aspergillus australensis Species 0.000 description 1
- 241001626694 Aspergillus austroafricanus Species 0.000 description 1
- 241001507831 Aspergillus avenaceus Species 0.000 description 1
- 241001194261 Aspergillus baeticus Species 0.000 description 1
- 241001043882 Aspergillus bahamensis Species 0.000 description 1
- 241000750544 Aspergillus biplanus Species 0.000 description 1
- 241000133623 Aspergillus bisporus Species 0.000 description 1
- 241001559572 Aspergillus bombycis Species 0.000 description 1
- 241000715761 Aspergillus brevistipitatus Species 0.000 description 1
- 241000981387 Aspergillus bridgeri Species 0.000 description 1
- 241000133662 Aspergillus brunneouniseriatus Species 0.000 description 1
- 241001182701 Aspergillus brunneoviolaceus Species 0.000 description 1
- 241000132184 Aspergillus brunneus Species 0.000 description 1
- 241000880414 Aspergillus caelatus Species 0.000 description 1
- 241000134821 Aspergillus caesiellus Species 0.000 description 1
- 241000750527 Aspergillus caespitosus Species 0.000 description 1
- 241000789823 Aspergillus calidoustus Species 0.000 description 1
- 241000131314 Aspergillus candidus Species 0.000 description 1
- 241000131965 Aspergillus carneus Species 0.000 description 1
- 241000133611 Aspergillus cervinus Species 0.000 description 1
- 241000019361 Aspergillus chungii Species 0.000 description 1
- 241000131375 Aspergillus clavatonanicus Species 0.000 description 1
- 241000228193 Aspergillus clavatus Species 0.000 description 1
- 241000134919 Aspergillus conicus Species 0.000 description 1
- 241000133610 Aspergillus conjunctus Species 0.000 description 1
- 241000715760 Aspergillus conversis Species 0.000 description 1
- 241001641617 Aspergillus coreanus Species 0.000 description 1
- 241000981364 Aspergillus coremiiformis Species 0.000 description 1
- 241001331771 Aspergillus costaricaensis Species 0.000 description 1
- 241000958633 Aspergillus costiformis Species 0.000 description 1
- 241001625599 Aspergillus creber Species 0.000 description 1
- 241001205401 Aspergillus cristatus Species 0.000 description 1
- 241000133639 Aspergillus crustosus Species 0.000 description 1
- 241001625598 Aspergillus cvjetkovicii Species 0.000 description 1
- 241000133597 Aspergillus deflectus Species 0.000 description 1
- 241001507825 Aspergillus dimorphicus Species 0.000 description 1
- 241001334092 Aspergillus discophorus Species 0.000 description 1
- 241000750532 Aspergillus diversus Species 0.000 description 1
- 241001277112 Aspergillus duricaulis Species 0.000 description 1
- 241000133637 Aspergillus eburneocremeus Species 0.000 description 1
- 241000071763 Aspergillus ecuadorensis Species 0.000 description 1
- 241000019362 Aspergillus effusus Species 0.000 description 1
- 241000133593 Aspergillus egyptiacus Species 0.000 description 1
- 241000131303 Aspergillus ellipticus Species 0.000 description 1
- 241000133613 Aspergillus elongatus Species 0.000 description 1
- 241001161135 Aspergillus falconensis Species 0.000 description 1
- 241001328415 Aspergillus fasciculatus Species 0.000 description 1
- 241000131363 Aspergillus fennelliae Species 0.000 description 1
- 241000228195 Aspergillus ficuum Species 0.000 description 1
- 241000464721 Aspergillus filifer Species 0.000 description 1
- 241001507828 Aspergillus flaschentraegeri Species 0.000 description 1
- 241000134991 Aspergillus flavipes Species 0.000 description 1
- 241000981368 Aspergillus flavofurcatus Species 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241000941334 Aspergillus flocculosus Species 0.000 description 1
- 241001161134 Aspergillus floriformis Species 0.000 description 1
- 241001161131 Aspergillus foeniculicola Species 0.000 description 1
- 241000892910 Aspergillus foetidus Species 0.000 description 1
- 241001522806 Aspergillus foveolatus Species 0.000 description 1
- 241000971750 Aspergillus fresenii Species 0.000 description 1
- 241000668757 Aspergillus fumigatiaffinis Species 0.000 description 1
- 241000824759 Aspergillus fumisynnematus Species 0.000 description 1
- 241000750534 Aspergillus funiculosus Species 0.000 description 1
- 241001507817 Aspergillus gorakhpurensis Species 0.000 description 1
- 241001084791 Aspergillus granulatus Species 0.000 description 1
- 241000750521 Aspergillus granulosus Species 0.000 description 1
- 241000132183 Aspergillus halophilicus Species 0.000 description 1
- 241001069733 Aspergillus helicothrix Species 0.000 description 1
- 241001187271 Aspergillus hennebergii Species 0.000 description 1
- 241000498303 Aspergillus heteromorphus Species 0.000 description 1
- 241000133595 Aspergillus heterothallicus Species 0.000 description 1
- 241000245637 Aspergillus heyangensis Species 0.000 description 1
- 241001194141 Aspergillus hiratsukae Species 0.000 description 1
- 241001199506 Aspergillus hollandicus Species 0.000 description 1
- 241001331777 Aspergillus homomorphus Species 0.000 description 1
- 241001294829 Aspergillus hortai Species 0.000 description 1
- 241000886819 Aspergillus ibericus Species 0.000 description 1
- 241000134989 Aspergillus iizukae Species 0.000 description 1
- 241000245598 Aspergillus implicatus Species 0.000 description 1
- 241001199500 Aspergillus insuetus Species 0.000 description 1
- 241000981386 Aspergillus insulicola Species 0.000 description 1
- 241000132178 Aspergillus intermedius Species 0.000 description 1
- 241000178168 Aspergillus inuii Species 0.000 description 1
- 241001507852 Aspergillus itaconicus Species 0.000 description 1
- 241000750596 Aspergillus ivoriensis Species 0.000 description 1
- 241001480052 Aspergillus japonicus Species 0.000 description 1
- 241000131384 Aspergillus kambarensis Species 0.000 description 1
- 241000133634 Aspergillus kanagawaensis Species 0.000 description 1
- 241001199502 Aspergillus kassunensis Species 0.000 description 1
- 241000121500 Aspergillus keveii Species 0.000 description 1
- 241000560179 Aspergillus laciniosus Species 0.000 description 1
- 241001331782 Aspergillus lacticoffeatus Species 0.000 description 1
- 241000131305 Aspergillus lanosus Species 0.000 description 1
- 241001149711 Aspergillus lentulus Species 0.000 description 1
- 241000131307 Aspergillus leporis Species 0.000 description 1
- 241000131373 Aspergillus longivesica Species 0.000 description 1
- 241000459887 Aspergillus luchuensis Species 0.000 description 1
- 241000750584 Aspergillus lucknowensis Species 0.000 description 1
- 241000134993 Aspergillus luppii Species 0.000 description 1
- 241001066423 Aspergillus luteovirescens Species 0.000 description 1
- 241000306807 Aspergillus medius Species 0.000 description 1
- 241000750587 Aspergillus microcysticus Species 0.000 description 1
- 241000241145 Aspergillus minisclerotigenes Species 0.000 description 1
- 241001199498 Aspergillus minutus Species 0.000 description 1
- 241001130783 Aspergillus miyajii Species 0.000 description 1
- 241000087011 Aspergillus montenegroi Species 0.000 description 1
- 241000455876 Aspergillus montevidensis Species 0.000 description 1
- 241000133640 Aspergillus multicolor Species 0.000 description 1
- 241000896360 Aspergillus multiplicatus Species 0.000 description 1
- 241001207320 Aspergillus muricatus Species 0.000 description 1
- 241000306555 Aspergillus navahoensis Species 0.000 description 1
- 241000941345 Aspergillus neobridgeri Species 0.000 description 1
- 241000132182 Aspergillus neocarnoyi Species 0.000 description 1
- 241000131350 Aspergillus neoglaber Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241001626676 Aspergillus nishimurae Species 0.000 description 1
- 241000131966 Aspergillus niveus Species 0.000 description 1
- 241000131308 Aspergillus nomius Species 0.000 description 1
- 241000668755 Aspergillus novofumigatus Species 0.000 description 1
- 241000750590 Aspergillus ochraceopetaliformis Species 0.000 description 1
- 241000981397 Aspergillus ochraceoroseus Species 0.000 description 1
- 241000122824 Aspergillus ochraceus Species 0.000 description 1
- 241001084793 Aspergillus olivicola Species 0.000 description 1
- 241001505568 Aspergillus omanensis Species 0.000 description 1
- 241000245580 Aspergillus onikii Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 241000981402 Aspergillus ostianus Species 0.000 description 1
- 241001232215 Aspergillus otanii Species 0.000 description 1
- 241001149667 Aspergillus pallidus Species 0.000 description 1
- 241000133608 Aspergillus panamensis Species 0.000 description 1
- 241000133605 Aspergillus parvathecius Species 0.000 description 1
- 241001328411 Aspergillus parvisclerotigenus Species 0.000 description 1
- 241000133627 Aspergillus parvulus Species 0.000 description 1
- 241000941343 Aspergillus persii Species 0.000 description 1
- 241000981370 Aspergillus petrakii Species 0.000 description 1
- 241000116955 Aspergillus phialiseptatus Species 0.000 description 1
- 241001331772 Aspergillus piperis Species 0.000 description 1
- 241000306561 Aspergillus primulinus Species 0.000 description 1
- 241000132180 Aspergillus proliferans Species 0.000 description 1
- 241001199499 Aspergillus protuberus Species 0.000 description 1
- 241001636296 Aspergillus pseudocaelatus Species 0.000 description 1
- 241000750575 Aspergillus pseudodeflectus Species 0.000 description 1
- 241000941338 Aspergillus pseudoelegans Species 0.000 description 1
- 241000087010 Aspergillus pseudonomius Species 0.000 description 1
- 241000905485 Aspergillus pseudotamarii Species 0.000 description 1
- 241001660627 Aspergillus pulverulentus Species 0.000 description 1
- 241001517194 Aspergillus pulvinus Species 0.000 description 1
- 241000133599 Aspergillus puniceus Species 0.000 description 1
- 241000306554 Aspergillus purpureus Species 0.000 description 1
- 241001161120 Aspergillus qinqixianii Species 0.000 description 1
- 241000133687 Aspergillus quadrilineatus Species 0.000 description 1
- 241000965925 Aspergillus rambellii Species 0.000 description 1
- 241000133652 Aspergillus raperi Species 0.000 description 1
- 241000133515 Aspergillus recurvatus Species 0.000 description 1
- 241000228254 Aspergillus restrictus Species 0.000 description 1
- 241001115403 Aspergillus rhizopodus Species 0.000 description 1
- 241000981369 Aspergillus robustus Species 0.000 description 1
- 241000133685 Aspergillus rugulosus Species 0.000 description 1
- 241001505555 Aspergillus rugulovalvus Species 0.000 description 1
- 241001331783 Aspergillus sclerotioniger Species 0.000 description 1
- 241000981372 Aspergillus sclerotiorum Species 0.000 description 1
- 241000981371 Aspergillus sepultus Species 0.000 description 1
- 241000131386 Aspergillus sojae Species 0.000 description 1
- 241000131371 Aspergillus spathulatus Species 0.000 description 1
- 241000133673 Aspergillus spectabilis Species 0.000 description 1
- 241000750638 Aspergillus spelunceus Species 0.000 description 1
- 241000720797 Aspergillus spiculosus Species 0.000 description 1
- 241001161138 Aspergillus spinulosporus Species 0.000 description 1
- 241000941328 Aspergillus steynii Species 0.000 description 1
- 241001277110 Aspergillus stramenius Species 0.000 description 1
- 241001507844 Aspergillus stromatoides Species 0.000 description 1
- 241001161118 Aspergillus sublatus Species 0.000 description 1
- 241000733582 Aspergillus sublevisporus Species 0.000 description 1
- 241000131306 Aspergillus subolivaceus Species 0.000 description 1
- 241000133624 Aspergillus subsessilis Species 0.000 description 1
- 241001277988 Aspergillus sydowii Species 0.000 description 1
- 241001625586 Aspergillus tabacinus Species 0.000 description 1
- 241000194466 Aspergillus taichungensis Species 0.000 description 1
- 241000134719 Aspergillus tamarii Species 0.000 description 1
- 241000525397 Aspergillus tardus Species 0.000 description 1
- 241001507822 Aspergillus terricola Species 0.000 description 1
- 241000131366 Aspergillus thermomutatus Species 0.000 description 1
- 241000965924 Aspergillus togoensis Species 0.000 description 1
- 241001482888 Aspergillus tonophilus Species 0.000 description 1
- 241001579053 Aspergillus tritici Species 0.000 description 1
- 241000228232 Aspergillus tubingensis Species 0.000 description 1
- 241000306560 Aspergillus udagawae Species 0.000 description 1
- 241001161117 Aspergillus undulatus Species 0.000 description 1
- 241000122816 Aspergillus unguis Species 0.000 description 1
- 241000131381 Aspergillus unilateralis Species 0.000 description 1
- 241001112078 Aspergillus usamii Species 0.000 description 1
- 241000122818 Aspergillus ustus Species 0.000 description 1
- 241000461757 Aspergillus uvarum Species 0.000 description 1
- 241000853023 Aspergillus vadensis Species 0.000 description 1
- 241000750642 Aspergillus varians Species 0.000 description 1
- 241001161119 Aspergillus venezuelensis Species 0.000 description 1
- 241000245649 Aspergillus violaceofuscus Species 0.000 description 1
- 241001277111 Aspergillus viridinutans Species 0.000 description 1
- 241001199486 Aspergillus vitricola Species 0.000 description 1
- 241000445051 Aspergillus welwitschiae Species 0.000 description 1
- 241001106599 Aspergillus westerdijkiae Species 0.000 description 1
- 241000133527 Aspergillus xerophilus Species 0.000 description 1
- 241000241270 Aspergillus zhaoqingensis Species 0.000 description 1
- 244000237138 Asphodeline lutea Species 0.000 description 1
- 241000837162 Astragalus aureus Species 0.000 description 1
- 241001213629 Astragalus brevipes Species 0.000 description 1
- 241000293273 Astragalus cibarius Species 0.000 description 1
- 241001205687 Astragalus eburneus Species 0.000 description 1
- 241001230053 Astragalus griseus Species 0.000 description 1
- 241001075250 Astragalus microcephalus Species 0.000 description 1
- 241000872937 Astragalus nigricans Species 0.000 description 1
- 241001288824 Astragalus paradoxus Species 0.000 description 1
- 241001314667 Astragalus rufescens Species 0.000 description 1
- 241001290708 Astragalus sparsus Species 0.000 description 1
- 241001067376 Astragalus spinosus Species 0.000 description 1
- 241000148009 Astragalus variabilis Species 0.000 description 1
- 240000005361 Athamanta cretensis Species 0.000 description 1
- 241001666702 Atrazonotus umbrosus Species 0.000 description 1
- 241000572246 Avellinia michelii Species 0.000 description 1
- 241000597246 Awacaris yezoensis Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 101000583080 Bunodosoma granuliferum Delta-actitoxin-Bgr2a Proteins 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
- 241000586568 Diaspidiotus perniciosus Species 0.000 description 1
- 241000556792 Diplocystis Species 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 101100226347 Escherichia phage lambda exo gene Proteins 0.000 description 1
- 241000040825 Espostoopsis dybowskii Species 0.000 description 1
- 244000041517 Etlingera elatior Species 0.000 description 1
- 241000188567 Eurybia spinulosa Species 0.000 description 1
- 102000036112 FAD binding proteins Human genes 0.000 description 1
- 108091000329 FAD binding proteins Proteins 0.000 description 1
- 108700005088 Fungal Genes Proteins 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- LUBKKVGXMXTXOZ-UHFFFAOYSA-N Geodin Natural products COC(=O)C1=CC(=O)C=C(OC)C11C(=O)C(C(O)=C(Cl)C(C)=C2Cl)=C2O1 LUBKKVGXMXTXOZ-UHFFFAOYSA-N 0.000 description 1
- 241001053196 Glossoloma chrysanthum Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000287746 Mycena purpureofusca Species 0.000 description 1
- 101100453819 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) kgd gene Proteins 0.000 description 1
- 101710167853 N-methyltransferase Proteins 0.000 description 1
- 101150036369 NRPS2 gene Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101100517202 Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) NRPS1 gene Proteins 0.000 description 1
- 101100365763 Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) NRPS3 gene Proteins 0.000 description 1
- 241000221961 Neurospora crassa Species 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 101150026476 PAO1 gene Proteins 0.000 description 1
- 241000228150 Penicillium chrysogenum Species 0.000 description 1
- 241001066584 Phoma neerlandica Species 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- 102100029437 Serine/threonine-protein kinase A-Raf Human genes 0.000 description 1
- KYGRCGGBECLWMH-UHFFFAOYSA-N Sterigmatocystin Natural products COc1cc2OC3C=COC3c2c4Oc5cccc(O)c5C(=O)c14 KYGRCGGBECLWMH-UHFFFAOYSA-N 0.000 description 1
- UTSVPXMQSFGQTM-UHFFFAOYSA-N Sterigmatrocystin Natural products O1C2=CC=CC(O)=C2C(=O)C2=C1C(C1C=COC1O1)=C1C=C2OC UTSVPXMQSFGQTM-UHFFFAOYSA-N 0.000 description 1
- 241000946770 Streptomyces umbrinus Species 0.000 description 1
- 240000005146 Strobilanthes repanda Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000188578 Symphyotrichum depauperatum Species 0.000 description 1
- 241000363611 Synanthedon bibionipennis Species 0.000 description 1
- 241000669151 Synanthedon pyri Species 0.000 description 1
- 241001315198 Syncephalis Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241001149960 Tolypocladium inflatum Species 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 241000221566 Ustilago Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- COXWNIZQNAMTQL-UHFFFAOYSA-N alantrypinone Natural products C12=NC3=CC=CC=C3C(=O)N1C1C(=O)NC2(C)C2(C3=CC=CC=C3NC2=O)C1 COXWNIZQNAMTQL-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000011482 antibacterial activity assay Methods 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 238000012458 antifungal assay Methods 0.000 description 1
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
- ZNGSMORVYUMUDS-UHFFFAOYSA-N asperfuranone Natural products C1C(O)C(C)(O)C(=O)C=2C1=C(C(=O)C=CC(C)=CC(C)CC)OC=2 ZNGSMORVYUMUDS-UHFFFAOYSA-N 0.000 description 1
- ZNGSMORVYUMUDS-BYQFYWKXSA-N asperfuranone Chemical compound O=C([C@@](C)(O)[C@H](O)C1)C=2C1=C(C(=O)/C=C/C(/C)=C/[C@@H](C)CC)OC=2 ZNGSMORVYUMUDS-BYQFYWKXSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- RHGQIWVTIHZRLI-UHFFFAOYSA-N dihydrosterigmatocystin Natural products O1C2=CC=CC(O)=C2C(=O)C2=C1C(C1CCOC1O1)=C1C=C2OC RHGQIWVTIHZRLI-UHFFFAOYSA-N 0.000 description 1
- 238000002828 disc diffusion antibiotic sensitivity testing Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000003864 humus Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960004844 lovastatin Drugs 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000011177 media preparation Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000002663 nebulization Methods 0.000 description 1
- YDWVJROLLAILGE-VAAQKJRKSA-N neosartoricin Chemical compound C1=C(O)C=C2C(CC=C(C)C)=C(C[C@@](O)(CC(=O)\C=C(\C)O)[C@H](OC(C)=O)C3=O)C3=C(O)C2=C1O YDWVJROLLAILGE-VAAQKJRKSA-N 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 101150082708 pkiA gene Proteins 0.000 description 1
- 230000027086 plasmid maintenance Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229930001118 polyketide hybrid Natural products 0.000 description 1
- 125000003308 polyketide hybrid group Chemical group 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000019525 primary metabolic process Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- XDRBDKVSHABELK-UHFFFAOYSA-N serantrypinone Natural products C12=NC3=CC=CC=C3C(=O)N1C1C(=O)NC2(CO)C2(C3=CC=CC=C3NC2=O)C1 XDRBDKVSHABELK-UHFFFAOYSA-N 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- UTSVPXMQSFGQTM-DCXZOGHSSA-N sterigmatocystin Chemical compound O1C2=CC=CC(O)=C2C(=O)C2=C1C([C@@H]1C=CO[C@@H]1O1)=C1C=C2OC UTSVPXMQSFGQTM-DCXZOGHSSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 101150111745 sucA gene Proteins 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000007102 tryptic soy broth medium Substances 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/69—Increasing the copy number of the vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/20—Pseudochromosomes, minichrosomosomes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/70—Vectors containing special elements for cloning, e.g. topoisomerase, adaptor sites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/002—Vectors comprising a special origin of replication system inducible or controllable
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/10—Vectors comprising a special origin of replication system multiple origins of replication
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/55—Vectors comprising a special origin of replication system from bacteria
Definitions
- Sequence Listing which is a part of the present disclosure, includes text file 0749sequence_ST25.txt, an 86 kilobyte file created on Apr. 29, 2016. This file comprises primer nucleotide and/or amino acid sequences of the present invention.
- the subject matter of the Sequence Listing is incorporated herein by reference in its entirety.
- Fungi contain an extensive but unexplored biosynthetic capacity, and can serve as reservoirs for novel bioactive compounds (Kobayashi, A., et al., Agric. Biol. Chem., 1988, 52, 3119-3123.; Kuno, F., et al., J. Antibiot. (Tokyo), 1996, 49, 742-747; Kumar, C. G., et al, Lett. Appl. Microbiol., 2011, 53, 350-358; Wu, M. C., et al., Curr. Opin. Biotechnol., 2012, 23, 931-940; Du, L., et al., Angew. Chem. Int. Ed.
- Filamentous fungi produce secondary metabolites (SMs) which have historically been a rich source of lead compounds for the pharmaceutical industry.
- Fungi produce 45% of bioactive molecules from all microbial sources (Bérdy, J., J. Antibiot. (Tokyo), 2012, 65, 385-395).
- SMs secondary metabolites
- These compounds derived from terpene, polyketide, and non-ribosomal peptide pathways (Keller, N. P., et al., Nat Rev Microbiol. 2005, 3: 937-947), display a broad range of useful antibiotic and pharmaceutical activities.
- Fungal genomes can harbor 50 or more different SM gene clusters ranging from 20 to greater than 100 kb in size (Nordberg, H. et al., Nucleic Acids Res., 2014, 42(Database issue), D26-31). Conservative estimates suggest that there are more than 5 million fungal species (Blackwell, M., Am. J. Bot., 2011, 98, 426-438), of which fewer than 5% have been described and less than 1% are available in the world's culture collections (Colwell, R. R., Microbial biodiversity and biotechnology. Washington, D.C.: Joseph Henry Press; p. 279-88, 1997).
- each of these fungal genomes may harbor 50 or more different SM gene clusters ranging from 20 kb to greater than 100 kb in size (Nordberg, H. et al., Nucleic Acids Res., 2014, 42(Database issue), D26-31), the number of undiscovered SMs is presumably extremely large.
- heterologous SM genes Itoh, T. et al., Methods Mol Biol 2012, 944, 175-182; Chiang, Y. M., et al., J. Am. Chem. Soc., 2013, 135, 7720-7731; Nielsen, M. T., et al., PLoS ONE 2013, 8: e72871; Tsunematsu, Y., et al., Nat Prod Rep 2013, 30: 1139-1149; Yin, W. B., et al. ACS Synth Biol 2013, 2: 629-634).
- heterologous clusters in fungi is one approach to identify SM compounds, biosynthetic SM proteins and genes. Recently, this approach has been reported for synthesis of the A. terreus -encoded compounds geodin and asperfuranone in A. nidulans (Chiang, Y. M., et al., J. Am. Chem. Soc., 2013, 135, 7720-7731; Nielsen, M. T., et al., PLoS ONE, 2013, 8, e72871). A. nidulans was also used to heterologously express a dermatophyte-derived gene cluster responsible for the synthesis of neosartoricin B (Yin, W.
- yeast artificial chromosome YAC, Burke, D., et al., Science, 1987, 236, 806-812
- bacterial artificial chromosome BAC, Shizuya, H., et al., Proc. Natl. Acad. Sci. USA., 1992, 89, 8794-8797
- P1-derived artificial chromosome PAC, Vietnamese, P. A., et al., Nat. Genet., 1994, 6, 84-89
- E. coli -plant shuttle BAC also called binary BAC (BIBAC, Hamilton, C. M., Gene, 1997, 200, 107-116), E.
- E. coli - Streptomyces artificial chromosome ESAC, Sosio, M., et al., Nat. Biotechnol., 2000, 18, 343-345.
- ESAC Sosio, M., et al., Nat. Biotechnol., 2000, 18, 343-345.
- fungi A previously reported E. coli -fungus shuttle plasmid vector can neither accommodate nor maintain 100 kb or larger DNA fragments (Yin, W. B., et al., ACS Synth. Biol., 2013, 2, 629-634).
- A. nidulans AMA1 is a fungal replication element that has been used in an E. coli -fungus shuttle vector for small plasmids (Gems, D., et al., Gene, 1991, 98, 61-67; Aleksenko, A. and Clutterbuck, A., J. Fungal Genet. Biol., 1997, 21, 373-387; Kubodera, T. et al., Biosci. Biotechnol. Biochem., 2000, 64, 1416-1426). There were also fungal shuttle plasmids or vectors reported for integration (Tiburn, J., et al., Gene. 1983, 26:205-221; Golduran, G. H. and Morris, N.
- Bacterial artificial chromosomes have been widely used for genomic DNA sequencing, positional cloning, and mapping in prokaryotes and eukaryotes including filamentous fungi (Zhu, H., et al., Fungal Genet. Biol., 1997, 21, 337-347; Nishimura, M., et al., Biosci. Biotechnol. Biochem., 1998, 62, 1515-1521; Adler, H. et al., Rev. Med. Virol., 2003, 13, 111-121; Diener, S. E., et al., Fungal Genet. Biol., 2004, 41, 1077-1087; Srivastava, S.
- BACs Bacterial artificial chromosomes
- genomic regions can contain an excess of the restriction sites or lack them altogether, for example in regions of genomic DNA that contain highly repetitive sequences, such as centromeres and telomeres (Godiska, R., et al., Bias-Free Cloning of ‘Unclonable’ DNA for Simplified Genomic Finishing. In DNA Sequencing III: Dealing with Difficult Templates. Sudbury, M A: Jones and Bartlett Publishers: 2008). As a result, some sequences can be difficult or impossible to determine, even with multiple biased partial digestion libraries and up to 50 ⁇ coverage.
- DNA fragments from rare or frequent cutting genomic regions can be either too large or too small for DNA fragment fractionation and can be excluded from cloning.
- Fragmentation of high molecular weight (HMW) genomic DNA by mechanical shearing, such as sonication, nebulization and hydroshearing, can generate small DNA fragments (10 kb or smaller). These methods can be unsuitable for preparing fragments ranging from 100 kb-300 kb. Freeze-thaw cycles have been reported to result in large DNA fragmentation, but these methods are not efficient enough for routine use (Osoegawa, K., et al., Genomics., 2007, 89, 291-299).
- Red/ET Red alpha/beta or RecE/T
- Engineered large DNA or BACs have been routinely used for generating transgenic animals, such as mice, and for the functional study of large genes or pathways in mammals, such as humans (Johnson, S. J. and Wade-Martins, R. A., Biochem. Soc. Trans. 2011, 39, 862-867).
- BAC-based large gene expression in animal models cannot be directly applied to study fungal SM pathways or discovery of natural products (NPs).
- the present inventor has developed vectors and methods for generating libraries of SM gene clusters that can be propagated and expressed in a fungal host.
- the present teachings include a fungal artificial chromosome (FAC).
- a fungal artificial chromosome can comprise at least one bacterial origin of replication, a bacterial selectable marker gene, a fungal selectable marker gene and a fungal autonomous replicating element.
- a FAC can be a shuttle vector or plasmid that can replicate in a bacterial host such as, for example, and without limitation E. coli as well as a fungal host, such as, for example and without limitation a filamentous fungus such as an Aspergillus .
- the Aspergillus can be Aspergillus nidulans.
- a fungal artificial chromosome of the present teachings can be a dual-function fungal artificial chromosome (FACdual).
- a FACdual can comprise at least one bacterial origin of replication, a bacterial selectable marker gene, a fungal autonomous replicating element, an integration site for recombination with a host, an integrase gene, and a fungal selectable marker gene.
- the integration site can be, without limitation, an attP site.
- the integrase gene can be, without limitation, a fungal codon-optimized phi31 integrase gene.
- a FACdual can further comprise a fungal-operative promoter such as a fungal inducible promoter.
- the fungal-operative promoter can be operably linked to the integrase gene.
- a fungal inducible promoter can be an alcA(p) (Romero, B., et al., Fungal Genet. Biol. 2003 40, 103-114).
- a fungal inducible promoter can be a glaA(p) (Smith, T. L., et al., Gene, 1990, 88, 259-262).
- a fungal inducible promoter can be a sucA promoter (Roth, A. H., et al., Appl Microbiol Biotechnol., 2010, 86, 659-670).
- a fungal autonomous replicating element can be any fungal autonomous replicating element, such as, without limitation, an AMA1 autonomous replicating element.
- the present teachings include a fungal artificial chromosome integration vector (FACint).
- a fungal artificial chromosome integration vector can comprise at least one bacterial origin of replication, a bacterial selectable marker gene, two fungal DNA sequences in the same orientation, and a fungal selectable marker gene.
- the two fungal sequences can be sequences homologous to a host fungal DNA.
- two fungal homologous DNA sequences can be, for example and without limitation, Aspergillus 1,007-bp 5′trpC and 1,000-bp 3′trpC homologous sequences.
- a FACint can replicate in a prokaryotic host such as, without limitation, an E. coli .
- a FACint can integrate into the genome of a fungal host such as, without limitation, an Aspergillus fungus such as an Aspergillus nidulans .
- a FACint can serve as a shuttle vector or plasmid.
- the bacterial selectable marker gene can be any bacterial selectable marker gene known to skilled artisans, such as, but not limited to a kanamycin-resistance gene (kanR).
- a vector of the present teachings i.e., a FAC, a FACdual or a FACint of the present teachings, can further comprise a cloning site comprising a plurality of recognition sites for endonucleases that bind and cut DNA at specific sequences.
- Endonuclease recognition sequences include recognition sequences of restriction endonucleases from prokaryotes and homing endonucleases from eukaryotes (as used herein, “restriction enzymes”).
- a cloning site can comprise a plurality of recognition sites for restriction enzymes that generate incompatible (i.e., non-complementary or non-palindromic) single-stranded overhangs upon digestion of the FAC.
- a cloning site can include recognition sequences for one or more restriction enzymes such as, without limitation, Bsr I, I-CeuI, BstXI, I-SceI or a combination thereof.
- a recognition sequence can be a recognition sequence of a restriction enzyme such as, without limitation, BstXI, I-SceI or a combination thereof.
- a cloning site can include a pair of restriction enzyme recognition sites in a tandem orientation.
- a cloning site can include a pair of restriction enzyme recognition sites in an opposing, “head-to-head” orientation.
- a cloning site can include, in order, recognition sites for I-SceI, BstXI, BstXI, and I-SceI.
- the I-SceI sites can be in a head-to-head orientation with each other.
- the BstXI sites can be in a head-to-head orientation with each other.
- a cloning site can further comprise one or more recognition sites for other restriction enzymes such as, for example, Bam HI, Hind III, Eco RI, or NotI.
- a vector of the present teachings can be maintained and can replicate in a prokaryotic host such as, without limitation, an E. coli , or in a eukaryotic fungal host such as, without limitation, an Aspergillus such as A. nidulans.
- a vector of the present teachings can include a low-copy number bacterial origin of replication, an inducible high-copy number bacterial origin of replication, or a combination thereof, i.e., both a low-copy number and an inducible high-copy number bacterial origins of replication.
- a low-copy number bacterial origin of replication can be, for example and without limitation, an oriS.
- an inducible high-copy number bacterial origin of replication can be, for example and without limitation, an oriV.
- the high copy number origin of replication can be controlled by a replication initiation protein gene encoded in the E. coli host genome or a plasmid.
- the replication initiation protein gene can be TrfA.
- an inducible promoter can be operably linked to the replication initiation protein gene.
- the inducible promoter can be any bacterial inducible promoter, such as, without limitation, an arabinose-inducible promoter, a lac promoter, an IPTG-inducible T3 promoter, an IPTG-inducible T5 promoter or a rhamnose-inducible (rhaBAD) promoter.
- a vector of the present teachings can include one or more genes for selectable markers for bacteria such as E. coli , such as, without limitation, a chloramphenicol resistance gene (camR or CAT), kanR, ampR, genR, tetA, strepR, galK or a combination thereof.
- a selectable marker can be used for positive selection (e.g., selecting for the presence of ampicillin resistance or galK (galactokinase) activity) or negative selection (e.g., selecting for the absence of galK activity (Warming, S., et al., Nucleic Acids Res. 2005, Vol. 33, No. 4 e36)).
- a vector of the present teachings can include a fungal selectable marker gene, such as, without limitation, pyrG, ptrA, trpC or a combination thereof.
- a fungal selection marker gene can be a pyrG gene.
- a vector of the present teachings can include an insertion of DNA from an exogenous source.
- a DNA insert can be an insertion at the cloning site.
- a DNA insert can be from any source, such as a virus, a prokaryotic microorganism, a eukaryotic microorganism, a plant, an animal, a human, or a cDNA generated from an RNA.
- a source of DNA can be the genome of a eukaryotic microorganism, such as a yeast or a filamentous fungus.
- a source of DNA can be an Aspergillus fungus, including any Aspergillus species.
- a source of DNA can be an Aspergillus fungus other than Aspergillus nidulans .
- a source of a DNA insert can be an Aspergillus fungus such as, without limitation, A. acidus, A. aculeatinus, A. aculeatus, A. aeneus, A. affinis, A. alabamensis, A. alliaceus, A. amazonicus, A. ambiguus, A. amoenus, A. amstelodami, A. amyloliquefaciens, A. amylovorus, A. anomalus, A. anthodesmis, A. apicalis, A.
- coreanus A. coremiiformis, A. costaricensis, A. costiformis, A. creber, A. cretensis, A. cristatus, A. crustosus, A. crystallinus, A. cvjetkovicii, A. deflectus, A. delacroixii, A. americanus, A. densus, A. dentatulus, A. depauperatus, A. dessyi, A. digitatus, A. dimorphicus, A. diplocystis, A. discophorus, A. disjunctus, A. diversus, A. dorothicus, A. dubius, A. dubius, A.
- duricaulis duricaulis, A. dybowskii, A. eburneocremeus, A. eburneus, A. echinosporus, A. echinulatus, A. ecuadorensis, A. effusus, A. egyptiacus, A. elatior, A. elegans, A. ellipsoideus, A. ellipticus, A. elongatus, A. equitis, A. erythrocephalus, A. falconensis, A. fasciculatus, A. fennelliae, A. ferrugineus, A. ferrugineus, A. ficuum, A. fiemonthi, A.
- A. fimetarius A. fimeti, A. fischeri, A. fischerianus, A. flaschentraegeri, A. flavescens, A. flavidus, A. flavipes, A. flavofurcatus, A. flavoviridescens, A. flavus, A. flocculosus, A. floriformis, A. foeniculicola, A. foetidus, A. fonsecaeus, A. foutoynontii, A. foveolatus, A. fresenii, A. fruticans, A. fruticulosus, A. fujiokensis, A. fuliginosus, A.
- leporis A. leucocarpus, A. lignieresii, A. longivesica, A. longobasidia, A. luchensi, A. luchuensis, A. lucknowensis, A. luteoniger, A. luteovirescens, A. lutescens, A. luteus, A. macfiei, A. macrosporus, A. malignus, A. malodoratus, A. malvaceus, A. mandshuricus, A. manginii, A. mannitosus, A. maritimus, A. mattletii, A. maximus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimus, A. minimen
- ochraceopetaliformis A. ochraceoroseus, A. ochraceoruber, A. ochraceus, A. okazakii, A. olivaceofuscus, A. olivaceus, A. olivascens, A. olivicola, A. omanensis, A. onikii, A. oosporus, A. ornatulus, A. ornatus, A. oryzae, A. ostianus, A. otanii, A. ovalispermus, A. paleaceus, A. pallidus, A. panamensis, A. paradoxus, A. parasiticus, A. parrulus, A. parvathecius, A.
- parvisclerotigenus A. parviverruculosus, A. parvulu, A. paulistensi, A. penicillatus, A. peniciffiformis, A. peniciffioides, A. peniciffioideum, A. penicillopsis, A. periconioides, A. perniciosus, A. persii, A. petrakii, A. peyronelii, A. phaeocephalus, A. phialiseptatus, A. phoenicis, A. pidoplichknovii, A. piperis, A. polychromus, A. pouchetii, A. primulinus, A. profusus, A.
- proliferans A. protuberus, A. pseudocaelatus, A. pseudocarbonarius, A. pseudocitricus, A. pseudoclavatus, A. pseudodeflectus, A. pseudoelatior, A. pseudoelegans, A. pseudoflavus, A. pseudoglaucus, A. pseudoheteromorphus, A. pseudoniger, A. pseudoniger, A. pseudonomius, A. pseudotamarii, A. pulchellus, A. pulmonum - hominis, A. pulverulentus, A. pulvinus, A. puniceus, A. purpureofuscus, A. purpureus, A. pusillus, A. pyramidus, A. pyri, A.
- roseovelutinus A. roseus, A. roseus, A. roseus, A. roseus, A. ruber, A. rubrobrunneus, A. rubrum, A. rufescens, A. rugulosus, A. rugulovalvus, A. rutilans, A. sacchari, A. saitoi, A. salviicola, A. sartoryi, A. scheelei, A. schiemanniae, A. sclerogenus, A. sclerotficarbonarius, A. sclerotioniger, A. sclerotiorum, A. sejunctus, A. septatus, A. sepultus, A. silvaticus, A. simplex, A.
- A. sparsus A. spathulatus, A. spectabilis, A. spelunceus, A. spiculosus, A. spinosus, A. spinulosus, A. spiralis, A. stella - maris, A. stellatus, A. stellifer, A. stercoreus, A. sterigmatophorus, A. steynii, A. stramenius, A. striatulus, A. striatus, A. stromatoides, A. strychni, A. subfuscus, A. subgriseus, A. sublatus, A. sublevisporus, A. subolivaceus, A.
- togoensis A. tokelau, A. tonophilus, A. toxicarius, A. tritici, A. tsurutae, A. tuberculatus, A. tubingensis, A. tunetanus, A. udagawae, A. umbrinus, A. umbrosus, A. undulatus, A. unguis, A. unilateralis, A. usamii, A. ustilago, A. ustus, A. uvarum, A. vadensis, A. vancampenhoutii, A. varanasensis, A. variabilis, A. varians, A. variecolor, A. variegatus, A.
- A. velutinus A. venezuelensis, A. versicolor, A. vinosobubalinus, A. violaceobrunneus, A. violaceofuscus, A. violaceus, A. virens, A. viridigriseus, A. viridinutans, A. vitellinus, A. vitis, A. vitricola, A. wangduanlii, A. warcupii, A. wehmeri, A. welwitschiae, A. wentii, A. westendorpii, A. westerdijkiae, A. xerophilus, A. yezoensis, A. zhaoqingensis or A. zonatus.
- a vector of the present teachings can include an insert which can be at least 10 kb in length, at least 20 kb in length, at least 30 kb in length, at least 40 kb in length, at least 50 kb in length, at least 60 kb in length, at least 70 kb in length, at least 80 kb in length, at least 90 kb in length, at least 100 kb in length, at least 110 kb in length, or at least 120 kb in length.
- an insert can be up to 500 kb in length, up to 400 kb in length, up to 300 kb in length, up to 200 kb in length, or up to 150 kb in length.
- a vector of the present teachings can include an insert ranging, for example and without limitation, from 30 kb up to 500 kb, from 40 kb up to 400 kb, from 50 kb up to 300 kb, or from 100 kb to 500 kb.
- a vector of the present teachings can include an insert which can comprise, consist essentially of, or consist of at least one secondary metabolite (SM) gene cluster.
- a vector of the present teachings can include an insert which can comprise, consist essentially of, or consist of at least one secondary metabolite (SM) gene cluster and all genes of this gene cluster encoding a final metabolite product from a fungus.
- the SM gene cluster can be from a fungal species heterologous to a host fungal species of a vector of the present teachings.
- the SM gene cluster can be from a fungal species other than A. nidulans , and the host fungal species can be A.
- an insert comprising an SM gene cluster can be up to 500 kb in length, up to 400 kb in length, up to 300 kb in length, up to 200 kb in length, or up to 150 kb in length.
- a vector of the present teachings can include an SM gene cluster ranging, for example and without limitation, from 30 kb up to 500 kb, from 40 kb up to 400 kb, from 50 kb up to 300 kb, from 100 kb to 500 kb, from 100 kb to 400 kb, or from 100 kb to 300 kb.
- an SM gene cluster comprised by a vector of the present teachings can be a complete gene cluster.
- expression of an SM gene cluster in a heterologous fungal host can be used to recreate a biosynthetic pathway of a secondary metabolite.
- the present teachings include a host fungus comprising a vector of the present teachings (i.e., a FAC, a FACdual, or a FACint).
- the host fungus can be a filamentous fungus, such as, without limitation, an Aspergillus fungus.
- the fungus can be an Aspergillus nidulans fungus.
- a host fungus comprising a vector of the present teachings comprising an SM gene cluster can express genes of the cluster.
- genes of an SM gene cluster comprised by a vector of the present teachings are in a fungal environment, naturally occurring gene expression, post-transcriptional and post-translational regulation and modifications, as well as synthesis of secondary metabolites, can be duplicated or closely approximated.
- one or more genes of an SM gene cluster can be modified to effect an increase or a decrease in expression levels, or to alter protein structure.
- a secondary metabolite (SM) gene cluster comprised by vector of the present teachings can be modified with one or more targeted insertions, one or more targeted deletions, or a combination thereof.
- a modification can lead to enhanced expression of one or more genes comprised by an SM gene cluster.
- a modification can lead to reduced expression of one or more genes comprised by an SM gene cluster.
- a modification can lead to activation of a cryptic gene.
- a modification can be a targeted insertion into a specific site in an SM gene cluster.
- a modification can be a targeted deletion of a portion of an SM gene cluster.
- the vector can be a FAC, a FACdual a FACint of the present teachings.
- the present teachings include methods of inserting a DNA sequence into a targeted location in a secondary metabolite (SM) gene cluster.
- these methods can comprise providing a vector of the present teachings (i.e., a FAC, a FACdual or a FACint of the present teachings) comprising a secondary metabolite (SM) gene cluster; providing an insertion DNA comprising, consisting essentially of, or consisting of a) a first sequence homologous to a sequence flanking a first side of the targeted location, b) a sequence to be inserted, c) a second sequence homologous to a sequence flanking a second side of the targeted location and d) a bacterial selectable marker; transforming the vector and the insertion DNA into an E.
- the bacterial selectable marker of the insertion DNA can be a marker other than a bacterial selectable marker comprised by the vector prior to the transformation.
- the bacterial selectable marker can be a positive selection marker or a negative selection marker.
- the vector can be a FAC.
- the present teachings include methods of deleting a targeted DNA sequence from a secondary metabolite (SM) gene cluster.
- these methods can comprise providing a vector of the present teachings (i.e., a FAC, a FACdual or a FACint of the present teachings) comprising a secondary metabolite (SM) gene cluster; providing a deletion DNA comprising a) a first sequence homologous to a sequence flanking a first side of the targeted DNA sequence, b) a second sequence homologous to a sequence flanking a second side of the targeted DNA sequence, and c) a bacterial selectable marker; transforming the vector and the insertion DNA into an E.
- a vector of the present teachings i.e., a FAC, a FACdual or a FACint of the present teachings
- SM secondary metabolite
- the bacterial selectable marker of the deletion DNA can be a marker other than a bacterial selectable marker comprised by the vector prior to the transformation.
- the bacterial selectable marker can be a positive selection marker or a negative selection marker.
- the vector can be a FAC of the present teachings.
- the present teachings include methods of constructing unbiased libraries in a vector of the present teachings.
- these methods can comprise providing high molecular weight (HMW) genomic DNA from a source of DNA such as a fungus; mechanically shearing the HMW genomic DNA into fragments of 100 kb-300 kb in length; generating blunt ends on the DNA fragments; ligating restriction enzyme linkers such as BstXI linkers to the blunt ends, thereby generating linker-ligated DNA fragments; purifying the linker-ligated DNA fragments by pulse field gel electrophoresis; and ligating the purified and linker-ligated DNA fragments into a restriction enzyme-cut vector such as a BstXI-cut vector of the present teachings.
- HMW high molecular weight
- the methods can further comprise transforming a host microorganism with the ligated, restriction enzyme-cut vector.
- the host microorganism can be an E. coli or a second fungus such as, for example, an A. nidulans .
- the restriction enzyme can be BstXI.
- the vector can be a FAC of the present teachings.
- the source of the DNA can be a filamentous fungus such as, without limitation, an Aspergillus fungus, such as an Aspergillus other than A. nidulans .
- the host microorganism can be an Aspergillus fungus such as A.
- the source of high molecular weight genomic DNA can be a fungal species other than the host fungal species.
- the HMW genomic DNA can be fungal genomic DNA heterologous to the host fungal species.
- the HMW genomic DNA can be fungal genomic DNA comprising a secondary metabolite gene cluster.
- FIG. 1A-C illustrate diagrams of FAC vectors of the present teachings.
- FIG. 2A-B illustrate preparation of HMW genomic DNA from Aspergillus wentii and random shear FAC cloning results.
- FIG. 3A-C CHEFF gels showing that E. coli - Aspergillus shuttle BACs or FACs are successfully transferred from transformed strains of A. nidulans back into E. coli.
- FIG. 4A-B Illustrate schematic overview of one-step precise FAC modification and molecular confirmation of successful fusion PCR.
- FIG. 5 A CHEFF gel shows five precise gene deletions of AtFAC9J20 (FAC20).
- FIG. 6 A schematic diagram of assembling a synthetic SM gene cluster by the FAC system in A. nidulans.
- the present teachings provide vectors and methods for the production of unbiased large-insert genomic libraries, for capturing complete sets of large intact SM gene pathways from a fungus.
- the vectors can be used to shuttle large intact SM gene clusters between a fungal host and a bacterial host.
- A. nidulans can be used as a host for heterologous expression of SM gene clusters.
- vectors of the present teaching allow targeted modification of SM gene clusters with insertions and deletions using homologous recombination.
- the present inventor has constructed unbiased fungal shuttle BAC (FAC) libraries with average insert sizes of 100 kb or larger from six sequenced fungi: Aspergillus aculeatus, A. wentii, A. terreus, Fusarium solani, Penicillium expansum , and P. marneffei .
- the average insert size in each library is such that an individual vector can contain a complete SM pathway, or a fungal secondary metabolite gene cluster which can range from 20 kb to over 80 kb.
- one vector can comprise all the genes of a SM biosynthetic pathway.
- the new FAC libraries were created using randomly sheared DNA and without restriction partial digestion, another milestone in the field, removing bias and thus improving the quality of the library.
- the present inventor has successfully captured 263 of 271 intact SM gene clusters or pathways predicted from the 6 sequenced fungi as individual FAC clones (Table 1).
- a vector of the present teachings can contain a full-length SM gene cluster that can be regulated by the regulatory elements of a fungal host.
- a vector comprising an intact SM gene cluster (such as a vector comprising an insert of about 100 kb) can be modified by a Red/ET technique, for fungal functional SM study.
- the present teachings include methods for the precise modification of fungal intact SM gene clusters at any selected DNA sequence position. The methods can be used, for example and without limitation, for activating cryptic, silent and or low-expression SM gene clusters, characterizing a gene or genetic element within a fungal SM gene cluster, and natural product (NP) discovery. Examples of modifications of 55 SM gene clusters or pathways are listed in Table 2.
- an antibiotic resistance gene for example, but without limitation a resistance gene for kanamycin, ampicillin or carbenicillin, erythromycin, tetracycline, gentamicin sulfate, penicillin, streptomycin, spectromycin, or chloramphenicol
- a resistance gene for kanamycin, ampicillin or carbenicillin, erythromycin, tetracycline, gentamicin sulfate, penicillin, streptomycin, spectromycin, or chloramphenicol can be used to select bacterial colonies harboring a vector comprising a modified SM gene cluster.
- Such vectors can be grown in E. coli on LB media with antibiotics appropriate for the both the vector and RED/ET selection markers.
- a selected colony can be grown within one day.
- the present teachings include a fusion PCR approach which combines a selectable marker (e.g. KanR or galK gene) and a promoter (such as, but without limitation, gpdA(p), alcA(p), glaA(p), or pkiA(A)) as one PCR product for modifying a SM gene cluster (e.g. FIGS. 4A-B and 5 ).
- a selectable marker e.g. KanR or galK gene
- a promoter such as, but without limitation, gpdA(p), alcA(p), glaA(p), or pkiA(A)
- the present teachings include methods for expressing a toxic SM compound, without the need to coexpress a resistance gene that can transport a toxic SM compound out of the cell. These methods use a vector comprising an inducible strong promoter such as alcA(p). In these methods, cells are initially grown without an inducing agent. When the cells reach a sufficient density, an inducing agent is added, and the cells express the genes of a secondary metabolite pathway. This approach can be used for the production of a toxic SM compound.
- vectors of the present teaching provide tools for assembling synthetic SM gene clusters in A. nidulan by fungal homologous recombination ( FIG. 6 ).
- Individual genes for example Gene1, Gene2, and Gene3, or more, total ⁇ 100 kb in size
- an inducible strong promoter such as, but without limitation alcA(p)
- flanking homologous sequences about 1 kb, H1, H2, H3, H4 and more.
- H1, and H4 can be simultaneously transformed into A. nidulans to assemble the synthetic SM gene cluster by homologous recombination.
- Fungal selection markers such as AfpyroA and AfriboB (Szewczyk, E, et al., Nat. Protoc., 2006, 1, 3111-3120) can be used for the selection of a vector with a synthetic SM gene cluster.
- AfpyroA and AfriboB can be used for the selection of a vector with a synthetic SM gene cluster.
- a synthetic SM gene cluster-FAC of the present teachings can be isolated from A. nidulans and then shuttled back into E. coli .
- a FAC can be further modified, for example by adding regulatory elements or genes in E. coli or in vitro.
- the present teachings include methods for assembly of novel synthetic SM gene clusters in A. nidulan by fungal homologous recombination ( FIG. 6 )
- a plasmid that can be used as a fungal artificial chromosome can be a P1-based vector, a BAC-based vector, or a shuttle BAC vector that can be used to replicate large inserts in E. coli and fungal hosts.
- a vector of the present teachings can contain features for replication and maintenance of the plasmid in E. coli .
- a vector can comprise an origin of replication for E. coli , such as low-copy number origin, for example but without limitation an origin derived from an F plasmid.
- a low-copy number origin of replication can include, without limitation, an oriS.
- a vector can also comprise an origin of replication for E. coli that can be an inducible high-copy replication origin, such as, but without limitation, an oriV.
- a vector can also include an E.
- a vector can also comprise at least one cloning site, which can be a multiple cloning site.
- a cloning site can comprise a pair of restriction sites wherein digestion with a restriction enzyme generates non-complementary single-stranded overhangs that can be ligated to specific linkers.
- Suitable enzymes include enzymes that can produce non-complementary single-stranded overhangs, such as non-palindromic overhangs such as overhangs resulting from digestion with an enzyme such as, without limitation, BstXI, BseYI, I-CeuI, I-SceI, PI-PspI, PI-SceI, AIwNI, BgII, BsII, BstAPI, DrdI, MwoI, PfIMI, or SfiI.
- an enzyme such as, without limitation, BstXI, BseYI, I-CeuI, I-SceI, PI-PspI, PI-SceI, AIwNI, BgII, BsII, BstAPI, DrdI, MwoI, PfIMI, or SfiI.
- a second cloning site can comprise a pair restriction sites which flank the first cloning site enzyme cut sites wherein digestion with a second enzyme targeting these sites generates non-complementary single-stranded overhangs.
- Suitable enzymes include rare cutters that can create non-complementary single-stranded overhangs such as, but without limitation I-SceI, PI-PspI, and I-CeuI.
- the combination of these two restriction enzyme site pairs can facilitate clean excision of the cloned large DNA fragment and exchange with other FAC plasmids, such as FAC integration plasmids.
- the high-copy number origin of replication can be regulated by a replication initiation protein that can be integrated into a host E. coli cell's genome on an inducible promoter, such as but without limitation an arabinose inducible promoter, a T5 promoter, a T7 promoter, a rhaBAD promoter or a ⁇ -galactosidase promoter.
- the replication initiation protein can be, for example and without limitation, TrfA.
- a FAC vector can contain features for their replication in fungal cells. These include a fungal origin of replication, such as, but without limitation autonomous maintenance in Aspergillus (AMA1, SEQ ID NO: 8).
- a FAC vector can also contain a fungal selection marker gene, such as but without limitation, orotidine-5′-phosphate decarboxylase gene (pyrG, originated from A. parasiticus , SEQ ID NO: 9 and SEQ ID NO: 10), ptrA, or trpC.
- the present teachings include a FAC dual-function vector that can be maintained in E. coli as a fungal artificial chromosome, can be induced to integrate into the fungal genome, and can be used as a E. coli -fungus shuttle BAC vector.
- a dual function vector has the same features as a regular FAC vector as described supra, and an additional gene cassette: an attP site and an integrase gene, such as but without limitation a phi31 integrase gene, under the control of fungal inducible promoter, such as but without limitation, alcA promoter or glaA(p).
- the integrase gene can be codon optimized for fungal expression.
- a FAC system of the present teachings can be used in a wide variety of fungi, such as and without limitation Aspergillus aculeatus, A. terreus, A. wentii, Fusarium solani, Penicillium expansum, P. marneffei, Neurospora crassa , and fungi belonging to the phylum Ascomycetes.
- fungus refers to is any member of the group of eukaryotic organisms that includes unicellular microorganisms such as, without limitation, yeasts and molds, as well as multicellular fungi that produce familiar fruiting forms known as mushrooms. More particularly they are filamentous fungi or molds, such as, and without limitation, Aspergillus aculeatus, A. terreus, A. wentii, Fusarium solani, Penicillium expansum , and P. marneffei.
- SM Secondary metabolite
- SM gene cluster or pathway refers to a set of biosynthetic genes that comprise polynucleotide sequences encoding the proteins, such as but without limitation an enzyme, required for synthesis and activity of a secondary metabolite.
- SM gene clusters or pathways implement the conversion of a starting compound, such as but without limitation a substrate, into a final compound or NP.
- SM gene cluster or pathway refers to a SM gene cluster or pathway contains a complete set of biosynthetic genes and regulatory elements. Each fungal genome may harbor 50 or more different intact SM gene clusters ranging from 20 to more than 100 kb in size (Nordberg, H. et al., Nucleic Acids Res., 2014, 42(Database issue), D26-31).
- Fungal SM clusters usually comprise one or more backbone gene(s) such as polyketide synthases (PKSs), nonribosomal peptide synthetases (NRPSs), dimethylallyl tryptophan synthases (DMATs), and terpene cyclases (TCs), surrounded by genes for modifying enzymes including, but not limited to, oxidoreductases, oxygenases, dehydrogenases, reductases, and transferases (Keller, N. P. and Hohn, T. M., Fungal Genet. Biol. 1997, 21, 17-29; Walton, J. D., Fungal Genet. Biol., 2000, 30, 167-171).
- PPSs polyketide synthases
- NRPSs nonribosomal peptide synthetases
- DMATs dimethylallyl tryptophan synthases
- TCs terpene cyclases
- genes for modifying enzymes including, but not limited to, oxidore
- regulatory element refers to a nucleic acid sequence element that controls or influences the expression of a gene, such as a gene within a large polynucleotide insert from a gene cassette, genetic construct or a FAC vector.
- a regulatory element can be, for example and without limitation, a promoter, an enhancer, a transcription factor or control sequence, a translation control sequence, a temporal or tissue-specific regulatory element, a polyadenylation signal sequence, a 5′ or 3′ UTR, a repressor or a terminator.
- Regulatory elements can be homologous or heterologous to the large polynucleotide insert or intact SM gene cluster to be expressed from a FAC construct or vector as described herein.
- a regulatory element can be naturally occurring, endogenous, exogenous, and/or engineered with respect to the cell.
- “Compatible” as used herein refers to two nucleic acid ends may mean that the ends are either both blunt or contain complementary single strand overhangs, such as that created by mechanically shearing DNA followed by DNA end repair, DNA linker ligation, or after digestion with a restriction endonuclease. At least one of the ends may contain a 5′ phosphate group, which can allow ligation of the ends by a double-stranded DNA ligase.
- BstXI Linker (Klickstein, L. B. and Neve, R. L., Current Protocols in Molecular Biology, John Wiley & Sons, Inc. 1991, 5.6.1-5.6.10) as used herein refers to two partially complementary strands of DNA that are annealed to one another to produce a double-strand DNA molecule with an overhang complementary to one end of the BstXI cutting sequences as above.
- An example of a BstXI linker for ligation of the blunt ends of large DNA fragments is the following:
- the blunt ends of the BstXI linker can be designed to be complementary to large DNA fragments.
- the target large DNA fragments may be mechanically sheared DNA which is polished and made blunt by DNA end repairing enzyme mixture (Intact Genomics, St. Louis, Mo.).
- the blunt DNA can also be modified by non-template mediated addition of a single A nucleotide to each end of the target large DNA by Taq polymerase.
- the above linker can be modified with an additional single T nucleotide to the 3′ of BstXI Linker Top strand.
- “Shuttle bacterial artificial chromosome (BAC) vector” means a BAC vector that can be used for the transfer and the maintenance of genetic information from one (or more) donor bacterial species or strain(s) to one or more host organism(s) or strain(s) or species.
- FAC vector refers to a fungal artificial chromosome vector, or a shuttle BAC vector between E. coli and A. nidulans.
- Library refers to a plurality of clones each comprising an insert sequence and a vector.
- the present teachings provide for the preparation of ultra-high quality of high molecular weight (HMW) genomic DNA from a fungus and the generation of an unbiased large insert FAC library by randomly shearing with average insert size 100 kb or larger.
- the large DNA population of a library includes not only fragments of all biosynthetic loci in the fungal genome with minimal bias, but also each DNA molecule is large enough (100 kb or larger) to cover at least one of the intact SM gene clusters.
- High molecular weight (HMW) genomic DNA can be derived from any cultured, isolated, purified or mixed fungi, including fungi with published genome sequences.
- the HMW genomic DNA can be prepared directly from a population of uncultured fungi in their natural habitat, environment, or biomass without the need of fungal isolation and cultivation.
- HMW genomic DNA can include intact chromosomes or can be megabases in size.
- HMW genomic DNA For preparation of HMW genomic DNA, fungal cells, such as, but without limitation, spores, germinated spores, protoplasts, or nuclei can be collected and directly embedded in low-melting agarose plugs.
- the low-melt agarose plugs can be from about 0.4% to about 1% in concentration and can have a final concentration of about 0.5%.
- HMW genomic DNA can be purified by treatment with lauryl sarcosine and proteinase K in 0.5 M EDTA, pH 9.0.
- HMW genomic DNA can be prepared by preparing fungal protoplasts (Bok, J. W. and Keller, N. P., Methods Mol. Biol., 2012, 944, 163-174) and then embedding the fungal protoplasts in low melt agarose plugs.
- HMW genomic DNA can be used to generate unbiased large insert recombinant DNA libraries to cover large intact SM gene clusters wherein one clone contains an intact SM gene cluster or pathway.
- the present teachings provide for preparation of liquid HMW genomic DNA by either electroelution or Gelase digestion of the agarose DNA plugs.
- the liquid HMW genomic DNA can then be mechanically sheared by hydroshearing, repeated pipetting, low-speed vortexing or a combination thereof.
- Conditions for a given fungal genome can be determined by running sheared HMW genomic DNA on a CHEFF gel with the size range of about 100 kb to about 300 kb.
- the E. coli -fungal shuttle BAC vectors or FAC ( FIG. 1 ) vectors disclosed herein (see Example 1) can be used for BAC/FAC library construction with average inserts 100 kb or larger.
- the present inventor has demonstrated that the large-insert FACs (at least 150 kb) can be shuttled into the heterologous A. nidulans host for stable maintenance and NP discovery ( FIG. 3 , Bok, J. W., et al., BMC Genomics, 2015, 16, 343).
- HMW genomic DNA was sheared as described in Methods. To 400 ⁇ l of sheared HMW genomic DNA (100 ⁇ 300 kb), 5 ⁇ l of DNA end repairing enzyme mixture (Intact Genomics, St. Louis Mo.), 100 ⁇ l of 5 ⁇ DNA end repairing buffer to a total of 500 ⁇ l. The sample is mixed well by gently pipetting with a wide-bore tip and the reaction is incubated at room temperature for 30 min. The DNA end repairing enzymes are heat killed by incubating the large DNA end repair reaction at 70° C. for 15 min.
- DNA end repairing enzyme mixture Intact Genomics, St. Louis Mo.
- linker-ligated large DNA fragments are fractionated and excess BstXI linkers are removed by 1% agarose CHEFF gel electrophoresis at 0.5 ⁇ TBE, 6V/cm, 90 s/90 s for 16 hours and 4V/cm, 5 s/5 s for additional 8 hours.
- Lambda DNA ladder marker (Intact Genomics) is used as a control to recover 100 ⁇ 150, 150 ⁇ 210, 210 ⁇ 300 kb large DNA fractions as gel slices, and then the gel slices are placed into dialysis tubes and the DNA is electreluted, and then the purified linker-ligated large DNA fragments are dialyzed against 100 ml of ice-cold and autoclaved ultra-pure water at least 3 times, for one hour each.
- the cloning-ready BstXI-FAC vectors (20 ng/ ⁇ l, Intact Genomics) are mixed with the gel-purified BstXI-linker ligated DNA (2 ⁇ 3 ng/ ⁇ l) at 1:3 molar rate, and the ligation reaction is set at 16° C. for overnight.
- 200 ul large DNA (3 ng/ ⁇ l) is mixed with 10 ul of the FAC vector (20 ng/ ⁇ l), 60 ⁇ l of 5 ⁇ T4 ligation buffer, 30 ⁇ l of BAC cloning T4 ligase (intactgenomics), ligation reaction is set at 16° C. for overnight, preferably 12 ⁇ 18 hours.
- the large DNA fragments of the library are cloned into FAC vector(s) and serve as a screening library for covering the fungal SM gene clusters or pathways in E. coli .
- the large-insert FAC library has average insert size 100 kb or larger, therefore it is sufficient to contain at least one intact SM gene cluster in an individual FAC clone.
- the large-insert FAC library is unbiased and a FAC library with only 10 ⁇ , or even 5 ⁇ genome coverage can be enough to capture an entire set of intact SM gene clusters from a sequenced fungal genome or a fungal sample.
- the inventor can capture a complete set of intact SM gene clusters with 4 ⁇ 5 384-well plates of FAC clones (average about 100 kb, 4 ⁇ 5 ⁇ genome coverage) from all 6 fungi studied (Table 1; Bok, J. W., et al., BMC Genomics, 2015, 16, 343).
- FAC system is a shuttle BAC system
- vectors of the present teachings can be in the BAC/fosmid library screening techniques known in the art.
- sequence-based approaches can be used for FAC library screening such as PCR or colony hybridization (Zhang, H. B. and Wu, C. C., Plant Physiol. Biochem., 2001, 39, 1-15; Kang, H. S. and Brady, S. F., Angew. Chem. Int. Ed. Engl., 2013, 52, 11063-11067).
- sequence-based approaches involves the design of DNA probes or primers which are derived from conserved regions of already known genes or protein families, for example but without limitation, pooled FAC DNAs from each arrayed library are screened using degenerate primers designed to amplify the conserved domains/regions of PKS or NRPS (Kang, H. S. and Brady, S. F., Angew. Chem. Int. Ed. Engl., 2013, 52, 11063-11067). Positive FAC clones can be recovered from libraries by PCR screening of the respective pools, followed by screening of their plates, columns, and rows from which they are identified.
- Another sequence based approach is to use high throughput next generation sequencing of pooled FAC libraries by plate-column-row with multiplex barcodes.
- This strategy will reduce sequence complexity from whole fungal genomes into FAC pool-level (plate-column-row), therefore enabling the complete assembly of pooled FAC clones (each 100 kb or larger).
- the intact SM gene clusters will be identified by annotation of completely sequenced and assembled FAC clones.
- the individual SM gene cluster-containing FAC clones will then be de-convoluted by barcodes and plate-column-row coordinates.
- sequence-based approaches identify SM gene clusters and their FACs from fungi without the precondition of genome sequence or even metagenomes of unculturable fungal community.
- another sequence-based approach is used to sequence the FAC clone ends by the traditional Sanger sequencing method, then identify the entire set of intact SM gene cluster-containing FACs by aligning the FAC end sequences onto the fungal reference genome sequences.
- a next-generation sequence method may be used for this purpose with FAC DNA pooling and barcoding to reduce the sequencing cost.
- the parental strain RJW256 (pyrG89, pyroA4, Anku70::argB, ⁇ ST::afpyrG, veA1) was obtained by a sexual cross between LO4641 (riboB2, pyroA4, ⁇ ST::AfpyrG, ⁇ AN7909::afpyrG, ⁇ nku70::argB, veA1) and RJW113.5 ( ⁇ veA::argB, pyrG89).
- RJW256 was transformed with FAC plasmids to produce FAC recombinant strains.
- AST::AfpyrG indicates that the entire endogenous sterigmatocystin gene cluster was removed from A. nidulans.
- A. nidulans RDIT9.32 For antimicrobial activity tests, we used A. nidulans RDIT9.32, A. fumigatus 293, Candida albicans, Pseudomonas aeroginosa PAO1, Bacillus cereus U85, and Micrococcus luteus strains. All of the fungal and bacterial strains were maintained as frozen glycerol stocks at ⁇ 80° C. Fungal strains were grown at 37° C. on glucose minimal medium (GMM, Bok, J. W. and Keller, N. P., Eukaryot. Cell, 2004, 3, 527-535) and bacterial strains were cultured on tryptic soy broth medium.
- GMM glucose minimal medium
- a modified PEG-calcium based transformation method was applied to improve transformation.
- the described method (Bok, J. W. and Keller, N. P., Eukaryot. Cell, 2004, 3, 527-535) was modified as follows: 200 ⁇ L containing 107 A. nidulans RJW256 protoplasts mixed with 2 ⁇ g FAC DNA were gently placed over 200 ⁇ L of 30% PEG 4,000 with 50 mM CaCl 2 in a 1.5 mL centrifuge tube. The centrifuge tube with protoplasts was incubated 30 min on ice. After centrifuging the incubated mixture for 5 min at 250 ⁇ g, the solution was gently mixed using an autopipette.
- This mixture was then incubated for 10 minutes at room temperature before 1 mL of sorbitol-Tris-HCl-CaCl 2 (STC: 1.2M sorbitol, 10 mM Tris-HCl, 10 mM CaCl 2 pH 7.5) buffer was added and gently mixed into the solution. After transferring the mixture into a 13 mL tube, an additional 5 mL of STC was added into the tube and gently mixed. One mL of this final solution was distributed onto regeneration media to obtain transformants.
- STC 1.2M sorbitol, 10 mM Tris-HCl, 10 mM CaCl 2 pH 7.5
- A. nidulans FAC transformants were maintained on culture plates for three generations for phenotype and chemical screening.
- FAC recovery we prepared ⁇ 0.3 mL of 106/mL protoplasts from A. nidulans FAC strains and FAC DNA was isolated by the common alkali lysis method, and resuspended in 10 ⁇ L of TE. One microliter of recovered DNA was re-transformed back into E. coli cells (BAC cells, Intact Genomics).
- a disc-diffusion method (Bauer 1966) was used for antibiotic activity-guided screening.
- One plate of each A. nidulans FAC strain was inoculated on solid GMM and incubated for seven days at 37° C. Subsequently, the entire contents of the plates were collected and lyophilized for 48 hours. Samples were then pulverized with mortar and pestle prior to the addition of 10 mL of methanol. Air-dried methanol extracts were dissolved in 150 ⁇ L methanol for activity testing. Media preparation for antibacterial assays were performed as previously described (Bok, J. W. and Keller, N. P., Eukaryot. Cell, 2004, 3, 527-535).
- 106 spores mentioned in the section above were embedded in 5 mL soft GMM agar (0.75% agar) and overlaid on solid GMM. 10 ⁇ L out of the 150 ⁇ L methanol extract above was loaded on a 1 cm diameter paper disc for each assay. Assay plates were incubated for 24 to 48 hour at 37° C. and observed for antimicrobial activity.
- a 1:7 split was employed post-column, resulting in a flow rate of 25 ⁇ L/min being directed to the mass spectrometer.
- a Q-EXACTIVETM mass spectrometer (Thermo Fisher Scientific, Waltham, Mass.) was used for MS analysis with the following settings: capillary temperature 275° C., sheath gas 4 (arbitrary units), spray voltage 4.2 kV.
- Full MS spectra were acquired at 35,000 resolution for the mass range m/z 200 to 1500 for all samples. Following each full MS scan, the top 5 most intense ions were selected for a dependent MS2 scan.
- MS2 was conducted using higher-energy collisional dissociation (HCD) with a normalized collision energy of 30%.
- HCD collisional dissociation
- the SIEVE software suite (Thermo Fisher Scientific, Waltham, Mass.) was used for component detection and relative quantification of ions produced by electrospray during small molecule LC-HRMS. Component detection was performed using a mass tolerance of 10 part-per-million (ppm) and a retention time window of 2.5 min. A minimum intensity of 5 ⁇ 10 6 was selected as the threshold for defining a peak as a component. For each component, a selected ion chromatogram was created and the integrated intensity of the peak was calculated. Peak areas were normalized based on total ion current. To increase statistical power and confidence of the final analysis, the procedure adopted here involved a decoy approach to multiple hypothesis testing.
- the replicate data AtFAC6J7 was subjected to a uniqueness filter against processed LC-HRMS data generated from a control group of strains containing empty vectors, as well as 13 other strains containing a variety of other FACs with unique genetic content.
- all components were initially searched against a targeted accurate mass database consisting of known fungal metabolites produced by A. nidulans using a mass tolerance of 3 ppm. A dozen of these known compounds were present at consistent levels in nearly all samples, and were monitored to rapidly identify highly perturbed systems. All components were also searched against a comprehensive accurate mass database consisting of over 13,000 known fungal secondary metabolites. This fungal database was prepared using Antibase (2011), Dictionary of Natural Products (2013), as well as additional fungal natural products found in the literature (Caboche et al. 2008; Andersen et al. 2013).
- the BstXI Linker overhang is not complementary to itself, nor is the BstXI-cut vector (above).
- the preferred ligation reaction product can be a circle containing one vector joined to one large DNA fragment via a single adapter at each end. This molecule may be transformed into host cells to produce a clone.
- This example describes pFAC plasmid, a vector of the present teachings that maintains extra-chromosomes in A. nidulans.
- a FAC vector (pFAC, FIG. 1A , SEQ ID NO: 7) is a BAC-based shuttle vector that can shuttle large DNA between E. coli and A. nidulans hosts.
- E. coli origins of replication oriS and oriV.
- the first replication origin, oriS is derived from a low-copy F plasmid for BAC-based large DNA cloning and library construction.
- the second replication origin, oriV is an inducible high-copy replication origin oriV, which can produce higher yield of large inserts when grown in E.
- coli containing a TrfA gene under the control of an arabinose promoter when they are grown on arabinose containing media.
- pFAC also contains a chloramphenicol-resistance gene (cat) for plasmid selection.
- the plasmid contains a large DNA cloning site comprising pair of BstXI sites designed next to each other in oppose orientations. When digested with BstXI, this configuration produces a pair of identical BstXI overhangs, that are not self-complimentary, but are complimentary to unique BstXI linkers. Therefore, the digested vector will not religate itself, nor will the linkers concatermerize easily.
- I-SceI homing restriction sites were inserted flanking the BstXI cloning site in reverse orientations. These sites facilitate clean excision of the cloned large DNA fragment and exchange with pFACint cloning vector (see example 2).
- pFAC also contains features required for use in A. nidulans . These include a third replication origin, AMA1, the autonomous maintenance in Aspergillus (AMA1, SEQ ID NO: 8). This sequence is required for maintaining large intact SM pathways as extra-chromosomal elements, or FACs. pFAC also contains a fungal selection marker gene, the orotidine-5′-phosphate decarboxylase gene (pyrG from A. parasiticus , SEQ ID NO: 9 & 10).
- This example describes pFACint, a FAC integration vector.
- FAC integration vector (pFACint, FIG. 1B , SEQ ID NO: 11) is a BAC-based shuttle BAC vector that can shuttle large DNA between E. coli and A. nidulans hosts.
- E. coli origins of replication oriS and oriV.
- the first replication origin, oriS is derived from a low-copy F plasmid for BAC-based large DNA cloning and library construction.
- the second replication origin, oriV is an inducible high-copy replication origin oriV, which can produce higher yield of large inserts when grown in E.
- coli containing a TrfA gene under the control of an arabinose promoter when they are grown on arabinose containing media.
- pFACint carries kanamycin-resistance gene (kan) as a selection marker gene or cloning purposes, the plasmid contains a large DNA cloning site comprising pair of BstXI sites designed next to each other in oppose orientations.
- kan kanamycin-resistance gene
- I-SceI homing restriction sites Two I-SceI homing restriction sites were inserted flanking the BstXI cloning site in reverse orientations. These sites facilitate clean excision of the cloned large DNA fragment and exchange with pFAC cloning vector.
- the I-Sce-I homing restriction sites also facilitate clean excision of the large intact SM gene pathways from the genomic integration site of the heterologous host A. nidulans.
- pFACint also contains features integrating the plasmid into the A. nidulans genome: 1,000-bp 3′trpC (SEQ ID NO: 12) and 1,007-bp 5′trpC (SEQ ID NO: 13) homologous sequences, which were inserted flanking the I-Sce I restriction sites in the same orientations, thus enabling fungal site-specific integration of large pFACint clones into the A. nidulans trpC gene, which encodes a polypeptide homologous to polyketide.
- the plasmid also contains a fungal selection marker gene, the orotidine-5′-phosphate decarboxylase gene (pyrG, from A. parasiticus).
- This example describes the vector pFACdual.
- pFACdual plasmid which also substantially corresponds pFAC plasmid except that it includes an additional gene cassette: an attP site and a fungal codon-optimized phi31 integrase gene under the control of fungal inducible promoter, such as alcA(p). Therefore, the large DNA pFACdual clones are usually maintaining as FAC and also be able integrated into the fungal genome with an attB site whenever it is needed.
- pFACdual vector is a fungal dual-function vector (pFACdual, FIG. 1C , SEQ ID NO: 14), and can act as both a fungal artificial chromosome and an inducible fungal genomic integration vector, or it can be used as an E. coli - A. nidulans shuttle BAC vector.
- pFACdual has similar features as pFAC (see Example 1), but pFAC dual has an additional gene cassette: an attP site and a fungal codon-optimized phi31 integrase gene (SEQ ID NO: 16 and SEQ ID NO: 17) under the control of the inducible alcA fungal promoter (alcA(p), SEQ ID NO: 15). Therefore, the large DNA pFACdual clones are usually maintained as a FAC but can be induced to integratd into the fungal genome with an attB site.
- This example illustrates the preparation of high molecular weight A. wentii DNA.
- Aspergillus wentii strain DTO 134E9 was used as a proof of concept. Different fungal species/strain starting materials were compared to test for quality of high molecular weight (HMW) genomic DNA: spores, germinated spores, protoplasts, or nuclei obtained from protoplasts. The protoplast preparation method was performed as previously described (Bok, J. W. and Keller, N. P., Eukaryot. Cell, 2004, 3: 527-535).
- HMW high molecular weight
- protoplasts were lysed with 0.5% Triton X-100 in HMW DNA preparation buffer (0.5 M Sucrose, 80 mM KCl, 10 mM Tris, 10 mM EDTA, 1 mM sperm idine, 1 mM spermine, pH 9.4). The protoplasts in buffer were gently mixed, incubated on ice for 30 minutes, and the resulting nuclei pelleted at 1,800 ⁇ g for 20 minutes.
- HMW DNA preparation buffer 0.5 M Sucrose, 80 mM KCl, 10 mM Tris, 10 mM EDTA, 1 mM sperm idine, 1 mM spermine, pH 9.4
- the pellet ( ⁇ 5 ⁇ 10 8 )—of nuclei, protoplasts, germinated spores, or spores—was resuspended with the HMW DNA preparation buffer to a total volume of 0.6 mL, and an equal volume of 1% low melting agarose was then added to the buffer to a total volume of 1.2 mL at 45° C. This was sufficient to make 10 plugs (about 100 ⁇ L per plug) which solidified at 4° C. The plugs were then incubated at 50° C.
- lysis buffer/plug 0.5 M EDTA, pH 9.0, 1% lauryl sarcosine, 1 mg/mL proteinase K.
- the plugs were extensively washed in 10-20 volumes of the following buffers for one hour for each wash: once with buffer 1 (0.5 M EDTA, pH 9.0-9.3 at 50° C.), once with buffer 2 (0.05 M EDTA, pH 8.0 on ice), three times with buffer 3 (ice cold TE plus 0.1 mM phenylmethyl sulfonyl fluoride (PMSF) on ice), three times with buffer 4 (ice cold TE on ice) and finally all plugs were stored in TE at 4° C.
- buffer 1 0.5 M EDTA, pH 9.0-9.3 at 50° C.
- buffer 2 0.05 M EDTA, pH 8.0 on ice
- buffer 3 ice cold TE plus 0.1 mM phenylmethyl sulfonyl fluoride (PMSF) on ice
- buffer 4
- FIG. 2A shows a CHEF gel that contains A. wentii HMW genomic DNA ranging from greater than 50 kb but mainly Mb sizes of DNA fragments.
- This example illustrates the construction of unbiased shuttle BAC library of A. wentii DNA.
- the HMW genomic DNA obtained from the protoplast preparation in Example 2 ranged from 50 ⁇ >1,000 kb (mainly megabase sized fragments).
- the HMW DNA from three plugs was end-repaired with the DNA end repair enzyme kit (Intact Genomics) in a total volume of 500 ⁇ L with 10 ⁇ L of the end repair enzymes which were then heat inactivated (70° C., 15 min).
- the resulting DNA was ligated with BstXI adaptors (10 ⁇ L of 100 ⁇ M each) and 10 ⁇ L ligase (2 U/ ⁇ L, Intact Genomics) in a total volume of 700 ⁇ L.
- Gel-fractionated DNA fragments ranging from 100 to 200 kb were purified by PFGE.
- 2B illustrates that the average insert size was estimated at ⁇ 100 kb (M, Lambda ladder Marker).
- This example illustrates BAC/FAC end sequencing, and select SM cluster-containing candidate FAC clones.
- BAC-end sequences of 1,536 clones from the unbiased Random Shear FAC library of A. wentii were completed by the Sanger BigDye sequencing method.
- the software Phred was used for base calling and sequence trimming.
- Vector masking was achieved using the DNAStar SeqMan Pro software package.
- the BAC end sequences were aligned against the A. wentii reference genome sequence by BLAST Assembled Genomes (NCBI). All 47 SM clusters-containing candidate FAC clones were successfully identified based on the FAC end sequence flanking one end of a SM cluster and the other FAC end sequence flanking the other end of the same SM cluster.
- This example illustrates construction of unbiased shuttle BAC library of A. wentii DNA and heterologous expression of SM clusters as FACs in A. nidulans.
- A. wentii was used as an example for shuttle BAC DNA library construction, and it has a fully sequenced genome containing 47 annotated SM gene clusters (Cerqueira, G. C., et al., Nucleic Acids Res., 2013, 42(Database issue), D705-D710).
- High molecular weight genomic DNA was prepared from A. wentii (see Example 4) and construction of the unbiased FAC library (see Example 5) resulted in ⁇ 20 ⁇ genome coverage of the A. wentii genome, or a total of 7,680 FAC clones with an average insert size of 100 kb ( FIG. 2A-B ).
- the FAC library was arrayed into 384-well plates and both ends of 1,536 FAC clones were sequenced.
- This example illustrates the validation of shuttle functions of FACs.
- nidulans transformants AtFAC9O3 ( ⁇ 100 kb), AtFAC9A23 ( ⁇ 80 kb), and AtFAC7A10 ( ⁇ 90 kb) respectively.
- the 2nd and 3rd (D) lane(s) on the left hand side of the gels is the control FAC used to transform A. nidulans . All recovered FACs were digested with NotI, there is no obvious large mutation observed.
- M Lambda ladder Marker. This was the first demonstration of the capability of AMA1 in supporting autonomous replication (FAC) of large DNA constructs at least 150 kb in A. nidulans .
- This example illustrates LC-HRMS linked FAC SM discovery.
- A. nidulans AtFAC9D19 strain samples were prepared as described in the Methods section.
- A. nidulans AtFAC9D19 was found to produce the insecticide compounds: alantrypinone, serantrypinone, alantrypinene B, alantryleunone.
- A. nidulans AtFAC6J7 strain was also selected for initial proof-of-concept experiments, as it contained a cluster highly homologous to the recently characterized hexadehydroastechrome cluster in A. fumigatus (Yin, W. B., et al., ACS Synth. Biol., 2013, 2, 629-634,).
- AtFAC6J7 contains seven out of the eight genes found in the corresponding A. fumigatus cluster.
- AtFAC6J7 metabolites were identified by analyzing organic extracts of the A. nidulans AtFAC6J7 transformant and control A. nidulans using LC-HRMS. Following data acquisition, Sieve software was used for component detection and relative quantitation (see Methods).
- AtFAC6J7 extracts When comparing AtFAC6J7 extracts to control sample extracts (wild type and other FAC strains), a compound that was present only in the AtFAC6J7 extract was identified as terezine D by both accurate mass (0.3 part-per-million error) and tandem mass spectrometry (MS/MS or MS2).
- Terezine D is a stable intermediate of astechrome biosynthesis (Watanabe, T., et al., Bioorg. Med. Chem., 2009, 17, 94-111; Bok, J. W., et al. BMC Genomics, 2015, 16, 343).
- This example illustrates an antibiotic activity test against FAC clones.
- An antibiotic activity test was performed 14 FAC clones. Ten pl out of 150 ⁇ l methanol extract from FAC transformants cultured on GMM plate for 7 days at 37° C. were loaded on small disc (diameter: 1 cm) for antimicrobial activity test against Aspergillus spp., Candida albicans, Bacillus cereus, Micrococcus luteus and Pseudomonas aeruginosa . Antibiotic activity was observed against Bacillus cereus with two FAC extracts (Bok, J. W., et al. BMC Genomics, 2015, 16, 343).
- This example illustrates FAC recombineering and activating silent SM gene clusters.
- Red/ET tools were used to elucidate the biosynthesis of benzomalvins from A. terreus FAC AtFAC9J20.
- Two smaller-size constructs (33.372 kb AtFAC9J20 ⁇ #1 and 68.988 kb AtFAC9J20 ⁇ #2) were created from the FAC clone AtFAC9J20 (102.715 kb) using the NIH BAC recombineering tool with the Red/ET homologous recombination.
- FAC AtFAC7O19 To activate a weakly expressed SM gene cluster in FAC AtFAC7O19, we have successfully inserted the fungal strong promoter gpdAp in front of the start codon ‘ATG’ of the transcription factor (TF) gene in this cluster. FAC recombineering was performed as a two step process. The inventor inserted the galK gene and selected Gal+ colonies on minimal media plus chloramphenicol and galactose and then replaced galK with the gpdA promoter by counter-selecting galK ⁇ colonies on minimal media plus chloramphicol, 2-deoxy-galactose, and glycerol. Eight out of eight trials produced FAC mutation constructs.
- FIG. 4A Fusion PCR was performed ( FIG. 4A ) to combine the selectable marker (e.g. KanR or galK gene) and a promoter (gpdA(p) or any genetic element) as one PCR product for FAC recombineering.
- the strong fungal promoter gpdAp was inserted in front of the ATG start codon of SM cluster genes in FAC AtFAC7O19 with a kanamycin resistance gene.
- the Fusion PCR reactions are shown schematically in FIG. 4A (H1 and H2, homology sequences 1 and 2, respectively; cat, chloramphenicol acetyl transferase gene; FAC, origins of replication).
- the primers used were: 38TF-Kan-leftendF (5′-TGGGACTTTGTCGCTCACGATTCGCCGAGTTGTATGGGCTGACCAGTGACcgacctgcagcctgttga-3′, SEQ ID NO: 1) and Kan-leftendR (5′-GGTGCCCCAAGCCTTGGATCCGTCGAGGCTGATCAGCGAgctc-3′, SEQ ID NO: 2); gpdA-rightendF (5′-TCGCTGATCAGCCTCGACGGATCCAAGGCTTGGGGCACCtgcgtt-3′, SEQ ID NO: 3) and 38TF-gpdA-rightendR (5′-TCCTCATGAATTAGATGGTTAGATGGACCTACCATCAGGATAGGTTCCATtgtgatgtctgctcaagcggg-3′, SEQ ID NO: 4).
- the result of the one-step targeting event is the insertion of constitutively active Kan-resistance gene next to gpdAp into a defined position on the FAC by selection on LB media with kanamycin and chloramphenicol for the maintenance of the engineered FAC.
- the fusion PCR insertions were confirmed with PCR followed by Notl restriction analysis of FAC DNA from 7 clones after the insertion of the kan-gpdAp selection cassettes, as shown in the gels in FIG. 4B .
- the first lane is unmodified FAC AtFAC7O19 DNA, which was included as a control. All tested clones show the same pattern, had the intended insertion but no obvious mutation on the pulse field gel.
- M Lambda ladder Marker.
- the bacteria are now phenotypically Kan+.
- FIG. 5 shows the NotI restriction analysis of FAC miniprep DNA from 4 clones each were confirmed by PCR (M, Lambda ladder Marker). The second to last lane contains unmodified AtFAC9J20 DNA, which was included as a control. AtFAC9J20 contains 2 SM gene clusters.
- the five genes, all members of the same cluster, are 1.239-kb Mtase (dimethylallyltryptophan N-methyltransferase) gene, 3.334-kb NRPS1, 7.284-kb NRPS2, 7.815-kb NRPS3, and 7.741-kb PKS genes.
- Mtase dimethylallyltryptophan N-methyltransferase
- 3.334-kb NRPS1 7.284-kb NRPS2
- 7.815-kb NRPS3 7.741-kb PKS genes.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Mycology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
- This application is a continuation of U.S. application Ser. No. 15/143,493, filed Apr. 29, 2016, which claims the benefit of and priority to U.S. Provisional Application No. 62/286,542, filed Jan. 25, 2016, the entire disclosure of each is hereby incorporated by reference in its entirety.
- This invention was made with government support under R43/44AI094885 awarded by the National Institutes of Health. The government has certain rights in the invention.
- The Sequence Listing, which is a part of the present disclosure, includes text file 0749sequence_ST25.txt, an 86 kilobyte file created on Apr. 29, 2016. This file comprises primer nucleotide and/or amino acid sequences of the present invention. The subject matter of the Sequence Listing is incorporated herein by reference in its entirety.
- Fungi contain an extensive but unexplored biosynthetic capacity, and can serve as reservoirs for novel bioactive compounds (Kobayashi, A., et al., Agric. Biol. Chem., 1988, 52, 3119-3123.; Kuno, F., et al., J. Antibiot. (Tokyo), 1996, 49, 742-747; Kumar, C. G., et al, Lett. Appl. Microbiol., 2011, 53, 350-358; Wu, M. C., et al., Curr. Opin. Biotechnol., 2012, 23, 931-940; Du, L., et al., Angew. Chem. Int. Ed. Engl., 2014, 53, 804-809; Fang, S. M., et al., Mar. Drugs, 2014, 12, 1788-1814; Leitão, A. L. and Enguita, F. J., Microbiol. Res., 2014, 169, 652-665).
- Filamentous fungi produce secondary metabolites (SMs) which have historically been a rich source of lead compounds for the pharmaceutical industry. Fungi produce 45% of bioactive molecules from all microbial sources (Bérdy, J., J. Antibiot. (Tokyo), 2012, 65, 385-395). These compounds, derived from terpene, polyketide, and non-ribosomal peptide pathways (Keller, N. P., et al., Nat Rev Microbiol. 2005, 3: 937-947), display a broad range of useful antibiotic and pharmaceutical activities. A recent literature survey of fungal metabolites covering 1500 compounds that were isolated and characterized between 1993 and 2001, showed that more than half of the molecules had antibacterial, antifungal or antitumor activity (Pelaez, F., Handbook of Industrial Mycology (ed. An, Z.) 49-92 (Marcel Dekker, New York. 2005). Examples of fungal natural products having therapeutic or economic significance include the antibiotic penicillin from Penicillium chrysogenum, the immunosuppressant cyclosporine (a cyclic peptide) from Tolypocladium inflatum, and the cholesterol-lowering mevinolin (a.k.a. lovastatin, a polyketide) from Aspergillus terreus.
- Fungal genomes can harbor 50 or more different SM gene clusters ranging from 20 to greater than 100 kb in size (Nordberg, H. et al., Nucleic Acids Res., 2014, 42(Database issue), D26-31). Conservative estimates suggest that there are more than 5 million fungal species (Blackwell, M., Am. J. Bot., 2011, 98, 426-438), of which fewer than 5% have been described and less than 1% are available in the world's culture collections (Colwell, R. R., Microbial biodiversity and biotechnology. Washington, D.C.: Joseph Henry Press; p. 279-88, 1997). In addition, because each of these fungal genomes may harbor 50 or more different SM gene clusters ranging from 20 kb to greater than 100 kb in size (Nordberg, H. et al., Nucleic Acids Res., 2014, 42(Database issue), D26-31), the number of undiscovered SMs is presumably extremely large.
- Several approaches to induce expression of SM clusters have been successful. These include overexpressing cluster-specific transcription factors or enzymatic genes, deleting or overexpressing chromatin-modifying genes, overexpressing trans-acting activators and deleting trans-acting inhibitors (Palmer, J. M. and Keller, N. P., Curr. Opin. Microbiol. 2010, 13: 431-436; Brakhage, A. A. and Schroeckh, V., Fungal Genet. Biol., 2011, 48, 15-22; Strauss, J. and Reyes-Dominguez, Y., Fungal Genet. Biol., 2011, 48, 62-69; Hong, S. Y., et al., Toxins (Basel) 2013, 5, 683-702). expression of heterologous SM genes (Itoh, T. et al., Methods Mol Biol 2012, 944, 175-182; Chiang, Y. M., et al., J. Am. Chem. Soc., 2013, 135, 7720-7731; Nielsen, M. T., et al., PLoS ONE 2013, 8: e72871; Tsunematsu, Y., et al., Nat Prod Rep 2013, 30: 1139-1149; Yin, W. B., et al. ACS Synth Biol 2013, 2: 629-634).
- Expression of heterologous clusters in fungi is one approach to identify SM compounds, biosynthetic SM proteins and genes. Recently, this approach has been reported for synthesis of the A. terreus-encoded compounds geodin and asperfuranone in A. nidulans (Chiang, Y. M., et al., J. Am. Chem. Soc., 2013, 135, 7720-7731; Nielsen, M. T., et al., PLoS ONE, 2013, 8, e72871). A. nidulans was also used to heterologously express a dermatophyte-derived gene cluster responsible for the synthesis of neosartoricin B (Yin, W. B., et al., ACS Synth. Biol., 2013, 2, 629-634). These studies utilized a shuttle vector that included a ColE1 origin of replication, a yeast centromere sequence and an autonomously replicating sequence. This vector was used to create a single full length cluster in A. nidulans. These technologies require considerable time and effort to express just one heterologous cluster. These technologies are also only compatible with inserts smaller than about 20 kilobases (kb).
- Large insert DNA cloning vectors are well established in a variety of systems, including: yeast artificial chromosome (YAC, Burke, D., et al., Science, 1987, 236, 806-812), bacterial artificial chromosome (BAC, Shizuya, H., et al., Proc. Natl. Acad. Sci. USA., 1992, 89, 8794-8797), P1-derived artificial chromosome (PAC, Ioannou, P. A., et al., Nat. Genet., 1994, 6, 84-89), E. coli-plant shuttle BAC, also called binary BAC (BIBAC, Hamilton, C. M., Gene, 1997, 200, 107-116), E. coli-Streptomyces artificial chromosome (ESAC, Sosio, M., et al., Nat. Biotechnol., 2000, 18, 343-345). However these plasmid systems are not compatible with fungi. A previously reported E. coli-fungus shuttle plasmid vector can neither accommodate nor maintain 100 kb or larger DNA fragments (Yin, W. B., et al., ACS Synth. Biol., 2013, 2, 629-634).
- A. nidulans AMA1 is a fungal replication element that has been used in an E. coli-fungus shuttle vector for small plasmids (Gems, D., et al., Gene, 1991, 98, 61-67; Aleksenko, A. and Clutterbuck, A., J. Fungal Genet. Biol., 1997, 21, 373-387; Kubodera, T. et al., Biosci. Biotechnol. Biochem., 2000, 64, 1416-1426). There were also fungal shuttle plasmids or vectors reported for integration (Tiburn, J., et al., Gene. 1983, 26:205-221; Golduran, G. H. and Morris, N. R., Methods in Molecular Genetics 1995, 6, 48-65 Microbial Gene Techniques Edited by Kenneth W. Adolph; Kubodera, T., et al., Biosci. Biotechnol. Biochem., 2000, 64, 1416-1426; Arentshorst, M., et al., Fungal Biology and Biotechnology, 2015, 2, 2), autonomous replication or extra-chromosomal maintenance (Gems, D., et al., Gene, 1991, 98, 61 -67; Golduran, G. H. and Morris, N. R., Methods in Molecular Genetics 1995, 6, 48-65 Microbial Gene Techniques Edited by Kenneth W. Adolph; Kubodera, T. et al., Biosci. Biotechnol. Biochem., 2000, 64, 1416-1426). However, these shuttle plasmids or vectors cannot be used to clone and transform very large DNA (such as 20 kb or larger). A previous attempt to introduce up to 75 Kb of fungal DNA into Fusarium oxysporum and A. awamori using an Agrobacterium tumefaciens transformation system yielded few transformants with large DNA inserts. Furthermore, no attempts to examine stability of heterologous DNA, let alone expression, were made (Takken, F. L., et al., Curr. Genet., 2004, 45, 242-248).
- Bacterial artificial chromosomes (BACs) have been widely used for genomic DNA sequencing, positional cloning, and mapping in prokaryotes and eukaryotes including filamentous fungi (Zhu, H., et al., Fungal Genet. Biol., 1997, 21, 337-347; Nishimura, M., et al., Biosci. Biotechnol. Biochem., 1998, 62, 1515-1521; Adler, H. et al., Rev. Med. Virol., 2003, 13, 111-121; Diener, S. E., et al., Fungal Genet. Biol., 2004, 41, 1077-1087; Srivastava, S. K., et al., PLoS One 2014, 9: e81832). Although large-insert DNA systems have also been applied for heterologous expression of microbial natural product biosynthetic pathways and metagenomic studies, there has been limited success reported (Béjà, O., Curr. Opin. Biotechnol., 2004, 15, 187-190; Lorenz, P. and Eck, J., Nat. Rev. Microbiol., 2005, 3, 510-516; Ongley, S. E., et al., Nat. Prod. Rep., 2013, 30, 1121-1138). Challenges with these systems include: 1) DNA cloning bias; 2) small DNA insert size; 3) lack of advanced heterologous expression hosts and 4) insufficient high-resolution chemical and data analysis pipelines. One reason for these challenges is that to date almost all BAC libraries are produced using partial restriction digestion (Wu, C. C., et al., Encyclopedia of Molecular Cell Biology and Molecular Medicine Volume 3 (2nd Edition), Edited by Meyers R. A., Wiley-VCH Verlag GmbH: Weinheim, Germany 2004, pp 385-425 2004; Zhang, M., et al., Nat. Protoc., 2012, 7, 467-478). Partial restriction digestion can be biased because the occurrence of restriction sites is highly variable and non-random in any genome including fungal genomes. Certain genomic regions can contain an excess of the restriction sites or lack them altogether, for example in regions of genomic DNA that contain highly repetitive sequences, such as centromeres and telomeres (Godiska, R., et al., Bias-Free Cloning of ‘Unclonable’ DNA for Simplified Genomic Finishing. In DNA Sequencing III: Dealing with Difficult Templates. Sudbury, M A: Jones and Bartlett Publishers: 2008). As a result, some sequences can be difficult or impossible to determine, even with multiple biased partial digestion libraries and up to 50× coverage.
- Additionally, DNA fragments from rare or frequent cutting genomic regions can be either too large or too small for DNA fragment fractionation and can be excluded from cloning. Fragmentation of high molecular weight (HMW) genomic DNA by mechanical shearing, such as sonication, nebulization and hydroshearing, can generate small DNA fragments (10 kb or smaller). These methods can be unsuitable for preparing fragments ranging from 100 kb-300 kb. Freeze-thaw cycles have been reported to result in large DNA fragmentation, but these methods are not efficient enough for routine use (Osoegawa, K., et al., Genomics., 2007, 89, 291-299).
- Red/ET (Red alpha/beta or RecE/T) tools have been developed for efficient large DNA or BAC-based recombinant engineering (Copeland, N. G., et al., Nat. Rev. Genet. 2001, 2: 769-779; Muyrers, J. P. P. et al., Trends in Bioch. Sci., 2001, 26, 325-331). Engineered large DNA or BACs have been routinely used for generating transgenic animals, such as mice, and for the functional study of large genes or pathways in mammals, such as humans (Johnson, S. J. and Wade-Martins, R. A., Biochem. Soc. Trans. 2011, 39, 862-867).
- BAC-based large gene expression in animal models (Johnson, S. J. and Wade-Martins, R. A., Biochem. Soc. Trans. 2011, 39, 862-867) cannot be directly applied to study fungal SM pathways or discovery of natural products (NPs).
- There is thus an unmet need for new methods and compositions for cloning large stretches of fungal DNA, such as entire clusters of genes involved in biosynthesis of secondary metabolites.
- Because of an unmet need for new tools to study fungal genes, the present inventor has developed vectors and methods for generating libraries of SM gene clusters that can be propagated and expressed in a fungal host.
- In some embodiments, the present teachings include a fungal artificial chromosome (FAC). In various aspects, a fungal artificial chromosome can comprise at least one bacterial origin of replication, a bacterial selectable marker gene, a fungal selectable marker gene and a fungal autonomous replicating element. In various aspects, a FAC can be a shuttle vector or plasmid that can replicate in a bacterial host such as, for example, and without limitation E. coli as well as a fungal host, such as, for example and without limitation a filamentous fungus such as an Aspergillus. In some configurations, the Aspergillus can be Aspergillus nidulans.
- In some configurations, a fungal artificial chromosome of the present teachings can be a dual-function fungal artificial chromosome (FACdual). In various configurations, a FACdual can comprise at least one bacterial origin of replication, a bacterial selectable marker gene, a fungal autonomous replicating element, an integration site for recombination with a host, an integrase gene, and a fungal selectable marker gene. In some configurations, the integration site can be, without limitation, an attP site. In some configurations, the integrase gene can be, without limitation, a fungal codon-optimized phi31 integrase gene. In some configurations, a FACdual can further comprise a fungal-operative promoter such as a fungal inducible promoter. In various configurations, the fungal-operative promoter can be operably linked to the integrase gene. In various aspects, a fungal inducible promoter can be an alcA(p) (Romero, B., et al., Fungal Genet. Biol. 2003 40, 103-114). In various aspects, a fungal inducible promoter can be a glaA(p) (Smith, T. L., et al., Gene, 1990, 88, 259-262). In various aspects, a fungal inducible promoter can be a sucA promoter (Roth, A. H., et al., Appl Microbiol Biotechnol., 2010, 86, 659-670).
- In various configurations, a fungal autonomous replicating element can be any fungal autonomous replicating element, such as, without limitation, an AMA1 autonomous replicating element.
- In some embodiments, the present teachings include a fungal artificial chromosome integration vector (FACint). In various configurations, a fungal artificial chromosome integration vector can comprise at least one bacterial origin of replication, a bacterial selectable marker gene, two fungal DNA sequences in the same orientation, and a fungal selectable marker gene. In various configurations, the two fungal sequences can be sequences homologous to a host fungal DNA. In various configurations, two fungal homologous DNA sequences can be, for example and without limitation, Aspergillus 1,007-bp 5′trpC and 1,000-
bp 3′trpC homologous sequences. In various aspects, a FACint can replicate in a prokaryotic host such as, without limitation, an E. coli. In various aspects, a FACint can integrate into the genome of a fungal host such as, without limitation, an Aspergillus fungus such as an Aspergillus nidulans. In various aspects, a FACint can serve as a shuttle vector or plasmid. In various aspects, the bacterial selectable marker gene can be any bacterial selectable marker gene known to skilled artisans, such as, but not limited to a kanamycin-resistance gene (kanR). - In various configurations, a vector of the present teachings, i.e., a FAC, a FACdual or a FACint of the present teachings, can further comprise a cloning site comprising a plurality of recognition sites for endonucleases that bind and cut DNA at specific sequences. Endonuclease recognition sequences include recognition sequences of restriction endonucleases from prokaryotes and homing endonucleases from eukaryotes (as used herein, “restriction enzymes”). In some configurations, a cloning site can comprise a plurality of recognition sites for restriction enzymes that generate incompatible (i.e., non-complementary or non-palindromic) single-stranded overhangs upon digestion of the FAC. In some aspects, a cloning site can include recognition sequences for one or more restriction enzymes such as, without limitation, Bsr I, I-CeuI, BstXI, I-SceI or a combination thereof. In some aspects, a recognition sequence can be a recognition sequence of a restriction enzyme such as, without limitation, BstXI, I-SceI or a combination thereof. In some aspects, a cloning site can include a pair of restriction enzyme recognition sites in a tandem orientation. In some aspects, a cloning site can include a pair of restriction enzyme recognition sites in an opposing, “head-to-head” orientation. In some aspects a cloning site can include, in order, recognition sites for I-SceI, BstXI, BstXI, and I-SceI. In some aspects, the I-SceI sites can be in a head-to-head orientation with each other. In some aspects, the BstXI sites can be in a head-to-head orientation with each other. In some configurations, a cloning site can further comprise one or more recognition sites for other restriction enzymes such as, for example, Bam HI, Hind III, Eco RI, or NotI.
- In various configurations, a vector of the present teachings can be maintained and can replicate in a prokaryotic host such as, without limitation, an E. coli, or in a eukaryotic fungal host such as, without limitation, an Aspergillus such as A. nidulans.
- In some configurations, a vector of the present teachings can include a low-copy number bacterial origin of replication, an inducible high-copy number bacterial origin of replication, or a combination thereof, i.e., both a low-copy number and an inducible high-copy number bacterial origins of replication. In various aspects, a low-copy number bacterial origin of replication can be, for example and without limitation, an oriS. In various aspects, an inducible high-copy number bacterial origin of replication can be, for example and without limitation, an oriV. In various configurations, the high copy number origin of replication can be controlled by a replication initiation protein gene encoded in the E. coli host genome or a plasmid. In various configurations, the replication initiation protein gene can be TrfA. In various configurations, an inducible promoter can be operably linked to the replication initiation protein gene. In various configurations, the inducible promoter can be any bacterial inducible promoter, such as, without limitation, an arabinose-inducible promoter, a lac promoter, an IPTG-inducible T3 promoter, an IPTG-inducible T5 promoter or a rhamnose-inducible (rhaBAD) promoter.
- In some configurations, a vector of the present teachings can include one or more genes for selectable markers for bacteria such as E. coli, such as, without limitation, a chloramphenicol resistance gene (camR or CAT), kanR, ampR, genR, tetA, strepR, galK or a combination thereof. In various aspects, a selectable marker can be used for positive selection (e.g., selecting for the presence of ampicillin resistance or galK (galactokinase) activity) or negative selection (e.g., selecting for the absence of galK activity (Warming, S., et al., Nucleic Acids Res. 2005, Vol. 33, No. 4 e36)).
- In some configurations, a vector of the present teachings can include a fungal selectable marker gene, such as, without limitation, pyrG, ptrA, trpC or a combination thereof. In some aspects, a fungal selection marker gene can be a pyrG gene.
- In some configurations, a vector of the present teachings can include an insertion of DNA from an exogenous source. In various configurations, a DNA insert can be an insertion at the cloning site. In various configurations, a DNA insert can be from any source, such as a virus, a prokaryotic microorganism, a eukaryotic microorganism, a plant, an animal, a human, or a cDNA generated from an RNA. In some configurations, a source of DNA can be the genome of a eukaryotic microorganism, such as a yeast or a filamentous fungus. In some configurations, a source of DNA can be an Aspergillus fungus, including any Aspergillus species. In some configurations, a source of DNA can be an Aspergillus fungus other than Aspergillus nidulans. In some configurations, a source of a DNA insert can be an Aspergillus fungus such as, without limitation, A. acidus, A. aculeatinus, A. aculeatus, A. aeneus, A. affinis, A. alabamensis, A. alliaceus, A. amazonicus, A. ambiguus, A. amoenus, A. amstelodami, A. amyloliquefaciens, A. amylovorus, A. anomalus, A. anthodesmis, A. apicalis, A. appendiculatus, A. arachidicola, A. arenarius, A. arvii, A. asperescens, A. assulatus, A. astellatus, A. aurantiobrunneus, A. aureofulgens, A. aureolatus, A. aureoterreus, A. aureus, A. auricomus, A. australensis, A. austroafricanus, A. avenaceus, A. awamori, A. baeticus, A. bahamensis, A. biplanus, A. bisporus, A. bombycis, A. brasiliensis, A. brevipes, A. brevistipitatus, A. bridgeri, A. brunneo-uniseriatus, A. brunneoviolaceu, A. caelatus, A. caesiellus, A. caespitosus, A. calidoustus, A. campestris, A. candidus, A. capensis, A. carbonarius, A. carneus, A. cavernicola, A. cavernicola, A. cervinus, A. chevalieri, A. chungii, A. cibarius, A. clavatoflavus, A. clavatonanicus, A. clavatus, A. conicus, A. conjunctus, A. conversis, A. coreanus, A. coremiiformis, A. costaricensis, A. costiformis, A. creber, A. cretensis, A. cristatus, A. crustosus, A. crystallinus, A. cvjetkovicii, A. deflectus, A. delacroixii, A. delicatus, A. densus, A. dentatulus, A. depauperatus, A. dessyi, A. digitatus, A. dimorphicus, A. diplocystis, A. discophorus, A. disjunctus, A. diversus, A. dorothicus, A. dubius, A. dubius, A. duricaulis, A. dybowskii, A. eburneocremeus, A. eburneus, A. echinosporus, A. echinulatus, A. ecuadorensis, A. effusus, A. egyptiacus, A. elatior, A. elegans, A. ellipsoideus, A. ellipticus, A. elongatus, A. equitis, A. erythrocephalus, A. falconensis, A. fasciculatus, A. fennelliae, A. ferrugineus, A. ferrugineus, A. ficuum, A. fiemonthi, A. filifera, A. fimetarius, A. fimeti, A. fischeri, A. fischerianus, A. flaschentraegeri, A. flavescens, A. flavidus, A. flavipes, A. flavofurcatus, A. flavoviridescens, A. flavus, A. flocculosus, A. floriformis, A. foeniculicola, A. foetidus, A. fonsecaeus, A. foutoynontii, A. foveolatus, A. fresenii, A. fruticans, A. fruticulosus, A. fujiokensis, A. fuliginosus, A. fulvus, A. fumaricus, A. fumigatiaffinis, A. fumigatoides, A. fumigatus, A. fumisynnematus, A. fungoides, A. funiculosus, A. fuscus, A. galeritus, A. giganteus, A. gigantosulphureus, A. gigas, A. glaber, A. glaucoaffinis, A. glauconiveus, A. glaucus, A. globosus, A. godfrini, A. gorakhpurensis, A. gracilis, A. granulatus, A. granulosus, A. gratioti, A. greconis, A. griseus, A. guttifer, A. gymnosardae, A. halophilicus, A. halophilus, A. helicothrix, A. hennebergii, A. herbariorum, A. heterocaryoticus, A. heteromorphus, A. heterothallicus, A. heyangensis, A. hiratsukae, A. hollandicus, A. homomorphus, A. hortae, A. humicola, A. humus, A. ibericus, A. igneus, A. iizukae, A. implicatus, A. incrassatus, A. indicus, A. indohii, A. ingratus, A. insecticola, A. insuetus, A. insulicola, A. intermedius, A. inuii, A. itaconicus, A. ivoriensis, A. Janus, A. japonicus, A. Jeanselmei, A. kambarensis, A. kanagawaensis, A. kassunensis, A. katsuobushi, A. keveii, A. koningii, A. laciniosus, A. lacticoffeatus, A. laneus, A. lanosus, A. laokiashanensis, A. lateralis, A. lentulus, A. lepidophyton, A. leporis, A. leucocarpus, A. lignieresii, A. longivesica, A. longobasidia, A. luchensi, A. luchuensis, A. lucknowensis, A. luteoniger, A. luteovirescens, A. lutescens, A. luteus, A. macfiei, A. macrosporus, A. malignus, A. malodoratus, A. malvaceus, A. mandshuricus, A. manginii, A. mannitosus, A. maritimus, A. mattletii, A. maximus, A. medius, A. melitensis, A. melleus, A. meffinus, A. mencieri, A. michelii, A. microcephalus, A. microcysticus, A. microsporus, A. microthecius, A. micro viridicitrinus, A. minimus, A. minisclerotigenes, A. minor, A. minutus, A. miyajii, A. miyakoensis, A. mollis, A. montenegroi, A. montevidensis, A. mucoroides, A. mucoroideus, A. muelleri, A. multicolor, A. multiplicatus, A. muricatus, A. muscivora, A. mutabilis, A. mycetomi-villabruzzii, A. mycobanche, A. nakazawae, A. nantae, A. nanus, A. navahoensis, A. neobridgeri, A. neocarnoyi, A. neoeffipticus, A. neoglaber, A. nidulellus, A. niger, A. nigrescens, A. nigricans, A. nishimurae, A. niveoglaucus, A. niveus, A. noelting, A. nominus, A. nomius, A. novofumigatus, A. novus, A. ochraceopetaliformis, A. ochraceoroseus, A. ochraceoruber, A. ochraceus, A. okazakii, A. olivaceofuscus, A. olivaceus, A. olivascens, A. olivicola, A. omanensis, A. onikii, A. oosporus, A. ornatulus, A. ornatus, A. oryzae, A. ostianus, A. otanii, A. ovalispermus, A. paleaceus, A. pallidus, A. panamensis, A. paradoxus, A. parasiticus, A. parrulus, A. parvathecius, A. parvisclerotigenus, A. parviverruculosus, A. parvulu, A. paulistensi, A. penicillatus, A. peniciffiformis, A. peniciffioides, A. peniciffioideum, A. penicillopsis, A. periconioides, A. perniciosus, A. persii, A. petrakii, A. peyronelii, A. phaeocephalus, A. phialiseptatus, A. phoenicis, A. pidoplichknovii, A. piperis, A. polychromus, A. pouchetii, A. primulinus, A. profusus, A. proliferans, A. protuberus, A. pseudocaelatus, A. pseudocarbonarius, A. pseudocitricus, A. pseudoclavatus, A. pseudodeflectus, A. pseudoelatior, A. pseudoelegans, A. pseudoflavus, A. pseudoglaucus, A. pseudoheteromorphus, A. pseudoniger, A. pseudoniger, A. pseudonomius, A. pseudotamarii, A. pulchellus, A. pulmonum-hominis, A. pulverulentus, A. pulvinus, A. puniceus, A. purpureofuscus, A. purpureus, A. pusillus, A. pyramidus, A. pyri, A. qinqixianii, A. qizutongii, A. quadricinctus, A. quadricingens, A. quadrifidus, A. quadrilineatus, A. quercinus, A. quininae, A. quitensis, A. racemosus, A. raianus, A. rambellii, A. ramosus, A. raperi, A. recurvatus, A. rehmii, A. repandus, A. repens, A. reptans, A. restrictus, A. rhizopodus, A. robustus, A. roseoglobosus, A. roseoglobulosus, A. roseovelutinus, A. roseus, A. roseus, A. ruber, A. rubrobrunneus, A. rubrum, A. rufescens, A. rugulosus, A. rugulovalvus, A. rutilans, A. sacchari, A. saitoi, A. salviicola, A. sartoryi, A. scheelei, A. schiemanniae, A. sclerogenus, A. sclerotficarbonarius, A. sclerotioniger, A. sclerotiorum, A. sejunctus, A. septatus, A. sepultus, A. silvaticus, A. simplex, A. sojae, A. sparsus, A. spathulatus, A. spectabilis, A. spelunceus, A. spiculosus, A. spinosus, A. spinulosus, A. spiralis, A. stella-maris, A. stellatus, A. stellifer, A. stercoreus, A. sterigmatophorus, A. steynii, A. stramenius, A. striatulus, A. striatus, A. stromatoides, A. strychni, A. subfuscus, A. subgriseus, A. sublatus, A. sublevisporus, A. subolivaceus, A. subsessilis, A. subunguis, A. sulphureus, A. sulphureus, A. sunderbanii, A. sydowii, A. sylvaticus, A. syncephalis, A. tabacinus, A. taichungensis, A. takakii, A. taklimakanensis, A. tamari, A. tapirirae, A. tardus, A. tatenoi, A. terrestris, A. terreus, A. terricola, A. testaceocolorans, A. tetrazonus, A. thermomutatus, A. thomi, A. tiraboschii, A. togoensis, A. tokelau, A. tonophilus, A. toxicarius, A. tritici, A. tsurutae, A. tuberculatus, A. tubingensis, A. tunetanus, A. udagawae, A. umbrinus, A. umbrosus, A. undulatus, A. unguis, A. unilateralis, A. usamii, A. ustilago, A. ustus, A. uvarum, A. vadensis, A. vancampenhoutii, A. varanasensis, A. variabilis, A. varians, A. variecolor, A. variegatus, A. velutinus, A. venezuelensis, A. versicolor, A. vinosobubalinus, A. violaceobrunneus, A. violaceofuscus, A. violaceus, A. virens, A. viridigriseus, A. viridinutans, A. vitellinus, A. vitis, A. vitricola, A. wangduanlii, A. warcupii, A. wehmeri, A. welwitschiae, A. wentii, A. westendorpii, A. westerdijkiae, A. xerophilus, A. yezoensis, A. zhaoqingensis or A. zonatus.
- In various configurations, a vector of the present teachings (i.e., a FAC, a FACdual or a FACint of the present teachings) can include an insert which can be at least 10 kb in length, at least 20 kb in length, at least 30 kb in length, at least 40 kb in length, at least 50 kb in length, at least 60 kb in length, at least 70 kb in length, at least 80 kb in length, at least 90 kb in length, at least 100 kb in length, at least 110 kb in length, or at least 120 kb in length. In various configurations, an insert can be up to 500 kb in length, up to 400 kb in length, up to 300 kb in length, up to 200 kb in length, or up to 150 kb in length. Thus, in various configurations, a vector of the present teachings can include an insert ranging, for example and without limitation, from 30 kb up to 500 kb, from 40 kb up to 400 kb, from 50 kb up to 300 kb, or from 100 kb to 500 kb.
- In various configurations, a vector of the present teachings can include an insert which can comprise, consist essentially of, or consist of at least one secondary metabolite (SM) gene cluster. In various configurations, a vector of the present teachings can include an insert which can comprise, consist essentially of, or consist of at least one secondary metabolite (SM) gene cluster and all genes of this gene cluster encoding a final metabolite product from a fungus. In various aspect, the SM gene cluster can be from a fungal species heterologous to a host fungal species of a vector of the present teachings. In various aspects, the SM gene cluster can be from a fungal species other than A. nidulans, and the host fungal species can be A. nidulans. In various configurations, an insert comprising an SM gene cluster can be up to 500 kb in length, up to 400 kb in length, up to 300 kb in length, up to 200 kb in length, or up to 150 kb in length. Thus, in various configurations, a vector of the present teachings can include an SM gene cluster ranging, for example and without limitation, from 30 kb up to 500 kb, from 40 kb up to 400 kb, from 50 kb up to 300 kb, from 100 kb to 500 kb, from 100 kb to 400 kb, or from 100 kb to 300 kb. In various configurations, an SM gene cluster comprised by a vector of the present teachings can be a complete gene cluster. In some aspects, expression of an SM gene cluster in a heterologous fungal host can be used to recreate a biosynthetic pathway of a secondary metabolite.
- In various configurations, the present teachings include a host fungus comprising a vector of the present teachings (i.e., a FAC, a FACdual, or a FACint). In various aspects, the host fungus can be a filamentous fungus, such as, without limitation, an Aspergillus fungus. In various aspects, the fungus can be an Aspergillus nidulans fungus. In various configurations, a host fungus comprising a vector of the present teachings comprising an SM gene cluster can express genes of the cluster. Because the genes of an SM gene cluster comprised by a vector of the present teachings are in a fungal environment, naturally occurring gene expression, post-transcriptional and post-translational regulation and modifications, as well as synthesis of secondary metabolites, can be duplicated or closely approximated. In some aspects, one or more genes of an SM gene cluster can be modified to effect an increase or a decrease in expression levels, or to alter protein structure.
- In various configurations, a secondary metabolite (SM) gene cluster comprised by vector of the present teachings can be modified with one or more targeted insertions, one or more targeted deletions, or a combination thereof. In various aspects, a modification can lead to enhanced expression of one or more genes comprised by an SM gene cluster. In various aspects, a modification can lead to reduced expression of one or more genes comprised by an SM gene cluster. In various aspects, a modification can lead to activation of a cryptic gene. In various aspects, a modification can be a targeted insertion into a specific site in an SM gene cluster. In various aspects, a modification can be a targeted deletion of a portion of an SM gene cluster. In some aspects, the vector can be a FAC, a FACdual a FACint of the present teachings.
- In some embodiments, the present teachings include methods of inserting a DNA sequence into a targeted location in a secondary metabolite (SM) gene cluster. In various configurations, these methods can comprise providing a vector of the present teachings (i.e., a FAC, a FACdual or a FACint of the present teachings) comprising a secondary metabolite (SM) gene cluster; providing an insertion DNA comprising, consisting essentially of, or consisting of a) a first sequence homologous to a sequence flanking a first side of the targeted location, b) a sequence to be inserted, c) a second sequence homologous to a sequence flanking a second side of the targeted location and d) a bacterial selectable marker; transforming the vector and the insertion DNA into an E. coli strain that expresses Red/ET recombinase enzymes; and selecting a transformed E. coli cell that comprises the bacterial selectable marker. Without being limited by theory, it is believed that insertion of a sequence at a targeted location can be achieved through homologous recombination between the insertion DNA and the SM gene cluster comprised by the vector. In some configurations, the bacterial selectable marker of the insertion DNA can be a marker other than a bacterial selectable marker comprised by the vector prior to the transformation. In various configurations, the bacterial selectable marker can be a positive selection marker or a negative selection marker. In some aspects, the vector can be a FAC.
- In some embodiments, the present teachings include methods of deleting a targeted DNA sequence from a secondary metabolite (SM) gene cluster. In various configurations, these methods can comprise providing a vector of the present teachings (i.e., a FAC, a FACdual or a FACint of the present teachings) comprising a secondary metabolite (SM) gene cluster; providing a deletion DNA comprising a) a first sequence homologous to a sequence flanking a first side of the targeted DNA sequence, b) a second sequence homologous to a sequence flanking a second side of the targeted DNA sequence, and c) a bacterial selectable marker; transforming the vector and the insertion DNA into an E. coli strain that expresses Red/ET recombinase enzymes; and selecting a transformed E. coli cell that comprises the bacterial selectable marker. Without being limited by theory, it is believed that deletion of a targeted sequence can be achieved through homologous recombination between the deletion DNA and the SM gene cluster comprised by the vector. In some configurations, the bacterial selectable marker of the deletion DNA can be a marker other than a bacterial selectable marker comprised by the vector prior to the transformation. In various configurations, the bacterial selectable marker can be a positive selection marker or a negative selection marker. In some aspects, the vector can be a FAC of the present teachings.
- In some embodiments, the present teachings include methods of constructing unbiased libraries in a vector of the present teachings. In various configurations, these methods can comprise providing high molecular weight (HMW) genomic DNA from a source of DNA such as a fungus; mechanically shearing the HMW genomic DNA into fragments of 100 kb-300 kb in length; generating blunt ends on the DNA fragments; ligating restriction enzyme linkers such as BstXI linkers to the blunt ends, thereby generating linker-ligated DNA fragments; purifying the linker-ligated DNA fragments by pulse field gel electrophoresis; and ligating the purified and linker-ligated DNA fragments into a restriction enzyme-cut vector such as a BstXI-cut vector of the present teachings. In various aspects, the methods can further comprise transforming a host microorganism with the ligated, restriction enzyme-cut vector. In various configurations, the host microorganism can be an E. coli or a second fungus such as, for example, an A. nidulans. In various configurations, the restriction enzyme can be BstXI. In various configurations, the vector can be a FAC of the present teachings. In various aspects, the source of the DNA can be a filamentous fungus such as, without limitation, an Aspergillus fungus, such as an Aspergillus other than A. nidulans. In some aspects, the host microorganism can be an Aspergillus fungus such as A. nidulans. In various aspects, the source of high molecular weight genomic DNA can be a fungal species other than the host fungal species. In various aspects, the HMW genomic DNA can be fungal genomic DNA heterologous to the host fungal species. In various aspects, the HMW genomic DNA can be fungal genomic DNA comprising a secondary metabolite gene cluster.
-
FIG. 1A-C illustrate diagrams of FAC vectors of the present teachings. -
FIG. 2A-B illustrate preparation of HMW genomic DNA from Aspergillus wentii and random shear FAC cloning results. -
FIG. 3A-C CHEFF gels showing that E. coli-Aspergillus shuttle BACs or FACs are successfully transferred from transformed strains of A. nidulans back into E. coli. -
FIG. 4A-B Illustrate schematic overview of one-step precise FAC modification and molecular confirmation of successful fusion PCR. -
FIG. 5 A CHEFF gel shows five precise gene deletions of AtFAC9J20 (FAC20). -
FIG. 6 A schematic diagram of assembling a synthetic SM gene cluster by the FAC system in A. nidulans. - The present teachings provide vectors and methods for the production of unbiased large-insert genomic libraries, for capturing complete sets of large intact SM gene pathways from a fungus. The vectors can be used to shuttle large intact SM gene clusters between a fungal host and a bacterial host. A. nidulans can be used as a host for heterologous expression of SM gene clusters. In addition, vectors of the present teaching allow targeted modification of SM gene clusters with insertions and deletions using homologous recombination.
- The present inventor has constructed unbiased fungal shuttle BAC (FAC) libraries with average insert sizes of 100 kb or larger from six sequenced fungi: Aspergillus aculeatus, A. wentii, A. terreus, Fusarium solani, Penicillium expansum, and P. marneffei. The average insert size in each library is such that an individual vector can contain a complete SM pathway, or a fungal secondary metabolite gene cluster which can range from 20 kb to over 80 kb. In some configurations, one vector can comprise all the genes of a SM biosynthetic pathway.
- The new FAC libraries were created using randomly sheared DNA and without restriction partial digestion, another milestone in the field, removing bias and thus improving the quality of the library. With the FAC libraries, the present inventor has successfully captured 263 of 271 intact SM gene clusters or pathways predicted from the 6 sequenced fungi as individual FAC clones (Table 1).
- The present inventor has demonstrated that large vectors such as vectors comprising intact SM gene clusters can be shuttled into a fungal host for stable plasmid maintenance. In addition, heterologous expression in an A. nidulans host of large SM gene clusters that are at least 150 kb has been achieved. In some configurations, A vector of the present teachings can contain a full-length SM gene cluster that can be regulated by the regulatory elements of a fungal host.
- In some aspects, a vector comprising an intact SM gene cluster (such as a vector comprising an insert of about 100 kb) can be modified by a Red/ET technique, for fungal functional SM study. The present teachings include methods for the precise modification of fungal intact SM gene clusters at any selected DNA sequence position. The methods can be used, for example and without limitation, for activating cryptic, silent and or low-expression SM gene clusters, characterizing a gene or genetic element within a fungal SM gene cluster, and natural product (NP) discovery. Examples of modifications of 55 SM gene clusters or pathways are listed in Table 2.
- In some configurations, an antibiotic resistance gene (for example, but without limitation a resistance gene for kanamycin, ampicillin or carbenicillin, erythromycin, tetracycline, gentamicin sulfate, penicillin, streptomycin, spectromycin, or chloramphenicol), can be used to select bacterial colonies harboring a vector comprising a modified SM gene cluster. Such vectors can be grown in E. coli on LB media with antibiotics appropriate for the both the vector and RED/ET selection markers. In some aspects, a selected colony can be grown within one day.
- In some configurations, the present teachings include a fusion PCR approach which combines a selectable marker (e.g. KanR or galK gene) and a promoter (such as, but without limitation, gpdA(p), alcA(p), glaA(p), or pkiA(A)) as one PCR product for modifying a SM gene cluster (e.g.
FIGS. 4A-B and 5). - In some configurations, the present teachings include methods for expressing a toxic SM compound, without the need to coexpress a resistance gene that can transport a toxic SM compound out of the cell. These methods use a vector comprising an inducible strong promoter such as alcA(p). In these methods, cells are initially grown without an inducing agent. When the cells reach a sufficient density, an inducing agent is added, and the cells express the genes of a secondary metabolite pathway. This approach can be used for the production of a toxic SM compound.
- In some configurations, vectors of the present teaching provide tools for assembling synthetic SM gene clusters in A. nidulan by fungal homologous recombination (
FIG. 6 ). Individual genes (for example Gene1, Gene2, and Gene3, or more, total ˜100 kb in size) can be either completely synthesized according to bioinformatics designs or cloned and fused with an inducible strong promoter (such as, but without limitation alcA(p)) and flanking homologous sequences (about 1 kb, H1, H2, H3, H4 and more). These genes and the cloning ready vectors (pFAC or pFACdual) containing the flanking homologous sequences of the synthetic SM gene cluster (e.g. H1, and H4) can be simultaneously transformed into A. nidulans to assemble the synthetic SM gene cluster by homologous recombination. Fungal selection markers such as AfpyroA and AfriboB (Szewczyk, E, et al., Nat. Protoc., 2006, 1, 3111-3120) can be used for the selection of a vector with a synthetic SM gene cluster. Unlike the previous genomic integration reported in the art (Szewczyk, E., et al., Nat. Protoc., 2006, 1, 3111-3120; Chiang, Y. M., et al., J. Am. Chem. Soc., 2013, 135, 7720-7731), a synthetic SM gene cluster-FAC of the present teachings can be isolated from A. nidulans and then shuttled back into E. coli. In some configurations, a FAC can be further modified, for example by adding regulatory elements or genes in E. coli or in vitro. - In some configurations, the present teachings include methods for assembly of novel synthetic SM gene clusters in A. nidulan by fungal homologous recombination (
FIG. 6 ) - The present teachings disclose three types of vectors for the cloning of large inserts. These vectors can be used for replication and maintenance of large inserts as artificial chromosomes or for integration of large inserts into the host fungal genome. In various configurations, a plasmid that can be used as a fungal artificial chromosome can be a P1-based vector, a BAC-based vector, or a shuttle BAC vector that can be used to replicate large inserts in E. coli and fungal hosts.
- In various configurations a vector of the present teachings can contain features for replication and maintenance of the plasmid in E. coli. A vector can comprise an origin of replication for E. coli, such as low-copy number origin, for example but without limitation an origin derived from an F plasmid. A low-copy number origin of replication can include, without limitation, an oriS. A vector can also comprise an origin of replication for E. coli that can be an inducible high-copy replication origin, such as, but without limitation, an oriV. A vector can also include an E. coli selection marker gene, such as a gene that confers resistance to an antibiotic such as, but without limitation: chloramphenicol, kanamycin, ampicillin or carbenicillin, erythromycin, tetracycline, gentamicin sulfate, penicillin, streptomycin, or spectromycin. In some configurations, a vector can also comprise at least one cloning site, which can be a multiple cloning site. In some aspects, a cloning site can comprise a pair of restriction sites wherein digestion with a restriction enzyme generates non-complementary single-stranded overhangs that can be ligated to specific linkers. Suitable enzymes include enzymes that can produce non-complementary single-stranded overhangs, such as non-palindromic overhangs such as overhangs resulting from digestion with an enzyme such as, without limitation, BstXI, BseYI, I-CeuI, I-SceI, PI-PspI, PI-SceI, AIwNI, BgII, BsII, BstAPI, DrdI, MwoI, PfIMI, or SfiI. In some configuraitons, a second cloning site can comprise a pair restriction sites which flank the first cloning site enzyme cut sites wherein digestion with a second enzyme targeting these sites generates non-complementary single-stranded overhangs. Suitable enzymes include rare cutters that can create non-complementary single-stranded overhangs such as, but without limitation I-SceI, PI-PspI, and I-CeuI. Without being limited by theory, the combination of these two restriction enzyme site pairs can facilitate clean excision of the cloned large DNA fragment and exchange with other FAC plasmids, such as FAC integration plasmids. In various configurations, the high-copy number origin of replication can be regulated by a replication initiation protein that can be integrated into a host E. coli cell's genome on an inducible promoter, such as but without limitation an arabinose inducible promoter, a T5 promoter, a T7 promoter, a rhaBAD promoter or a β-galactosidase promoter. The replication initiation protein can be, for example and without limitation, TrfA.
- In some configurations, a FAC vector can contain features for their replication in fungal cells. These include a fungal origin of replication, such as, but without limitation autonomous maintenance in Aspergillus (AMA1, SEQ ID NO: 8). A FAC vector can also contain a fungal selection marker gene, such as but without limitation, orotidine-5′-phosphate decarboxylase gene (pyrG, originated from A. parasiticus, SEQ ID NO: 9 and SEQ ID NO: 10), ptrA, or trpC.
- In some configurations, the present teachings include a FAC dual-function vector that can be maintained in E. coli as a fungal artificial chromosome, can be induced to integrate into the fungal genome, and can be used as a E. coli-fungus shuttle BAC vector. A dual function vector has the same features as a regular FAC vector as described supra, and an additional gene cassette: an attP site and an integrase gene, such as but without limitation a phi31 integrase gene, under the control of fungal inducible promoter, such as but without limitation, alcA promoter or glaA(p). In various configurations, the integrase gene can be codon optimized for fungal expression.
- In various configuration, a FAC system of the present teachings can be used in a wide variety of fungi, such as and without limitation Aspergillus aculeatus, A. terreus, A. wentii, Fusarium solani, Penicillium expansum, P. marneffei, Neurospora crassa, and fungi belonging to the phylum Ascomycetes.
- Various terms are used herein to refer to aspects of the present teachings. To aid in the clarification of description of the components of these teachings, the following definitions are included.
- The term “fungus” as used herein refers to is any member of the group of eukaryotic organisms that includes unicellular microorganisms such as, without limitation, yeasts and molds, as well as multicellular fungi that produce familiar fruiting forms known as mushrooms. More particularly they are filamentous fungi or molds, such as, and without limitation, Aspergillus aculeatus, A. terreus, A. wentii, Fusarium solani, Penicillium expansum, and P. marneffei.
- “Secondary metabolite (SM)” as used herein refers to a chemical compound that is not involved in primary metabolism, and therefore differs from the more prevalent macromolecules such as proteins and nucleic acids. Thousands of SMs have been described from various eukaryotic organisms including fungi (Donadio, S., et al., Nat. Prod. Rep., 2007, 24, 1073-1109).
- “SM gene cluster or pathway” as used herein refers to a set of biosynthetic genes that comprise polynucleotide sequences encoding the proteins, such as but without limitation an enzyme, required for synthesis and activity of a secondary metabolite. SM gene clusters or pathways implement the conversion of a starting compound, such as but without limitation a substrate, into a final compound or NP.
- The term “intact or full-length SM gene cluster or pathway” used herein refers to a SM gene cluster or pathway contains a complete set of biosynthetic genes and regulatory elements. Each fungal genome may harbor 50 or more different intact SM gene clusters ranging from 20 to more than 100 kb in size (Nordberg, H. et al., Nucleic Acids Res., 2014, 42(Database issue), D26-31). Fungal SM clusters usually comprise one or more backbone gene(s) such as polyketide synthases (PKSs), nonribosomal peptide synthetases (NRPSs), dimethylallyl tryptophan synthases (DMATs), and terpene cyclases (TCs), surrounded by genes for modifying enzymes including, but not limited to, oxidoreductases, oxygenases, dehydrogenases, reductases, and transferases (Keller, N. P. and Hohn, T. M., Fungal Genet. Biol. 1997, 21, 17-29; Walton, J. D., Fungal Genet. Biol., 2000, 30, 167-171).
- “Regulatory element” as used herein refers to a nucleic acid sequence element that controls or influences the expression of a gene, such as a gene within a large polynucleotide insert from a gene cassette, genetic construct or a FAC vector. A regulatory element can be, for example and without limitation, a promoter, an enhancer, a transcription factor or control sequence, a translation control sequence, a temporal or tissue-specific regulatory element, a polyadenylation signal sequence, a 5′ or 3′ UTR, a repressor or a terminator. Regulatory elements can be homologous or heterologous to the large polynucleotide insert or intact SM gene cluster to be expressed from a FAC construct or vector as described herein. When a FAC vector as described herein is present in a cell such as a heterologous A. nidulans cell, a regulatory element can be naturally occurring, endogenous, exogenous, and/or engineered with respect to the cell.
- “Compatible” as used herein refers to two nucleic acid ends may mean that the ends are either both blunt or contain complementary single strand overhangs, such as that created by mechanically shearing DNA followed by DNA end repair, DNA linker ligation, or after digestion with a restriction endonuclease. At least one of the ends may contain a 5′ phosphate group, which can allow ligation of the ends by a double-stranded DNA ligase.
- “BstXI Linker” (Klickstein, L. B. and Neve, R. L., Current Protocols in Molecular Biology, John Wiley & Sons, Inc. 1991, 5.6.1-5.6.10) as used herein refers to two partially complementary strands of DNA that are annealed to one another to produce a double-strand DNA molecule with an overhang complementary to one end of the BstXI cutting sequences as above. An example of a BstXI linker for ligation of the blunt ends of large DNA fragments is the following:
-
(SEQ ID NO: 5) BstXI Linker Top 5′-CTGGAAAG-3′ (SEQ ID NO: 6) BstXI Linker Bottom 5′-CTTTCCAGCACA-3′ - The blunt ends of the BstXI linker can be designed to be complementary to large DNA fragments. For example, the target large DNA fragments may be mechanically sheared DNA which is polished and made blunt by DNA end repairing enzyme mixture (Intact Genomics, St. Louis, Mo.). The blunt DNA can also be modified by non-template mediated addition of a single A nucleotide to each end of the target large DNA by Taq polymerase. In this case, the above linker can be modified with an additional single T nucleotide to the 3′ of BstXI Linker Top strand.
- “Shuttle bacterial artificial chromosome (BAC) vector” means a BAC vector that can be used for the transfer and the maintenance of genetic information from one (or more) donor bacterial species or strain(s) to one or more host organism(s) or strain(s) or species.
- “FAC vector” as used herein refers to a fungal artificial chromosome vector, or a shuttle BAC vector between E. coli and A. nidulans.
- “Library” as used herein refers to a plurality of clones each comprising an insert sequence and a vector.
- Methods and compositions described herein utilize laboratory techniques well known to skilled artisans, and can be found in laboratory manuals such as Sambrook, J., et al., Molecular Cloning: A Laboratory Manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 2001; Spector, D. L. et al., Cells: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1998; Nagy, A., Manipulating the Mouse Embryo: A Laboratory Manual (Third Edition), Cold Spring Harbor, N.Y., 2003 and Harlow, E., Using Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1999. As used in the present description and any appended claims, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context indicates otherwise.
- The following materials and methods are also used in various aspects of the present teachings.
- The present teachings provide for the preparation of ultra-high quality of high molecular weight (HMW) genomic DNA from a fungus and the generation of an unbiased large insert FAC library by randomly shearing with
average insert size 100 kb or larger. The large DNA population of a library includes not only fragments of all biosynthetic loci in the fungal genome with minimal bias, but also each DNA molecule is large enough (100 kb or larger) to cover at least one of the intact SM gene clusters. - High molecular weight (HMW) genomic DNA can be derived from any cultured, isolated, purified or mixed fungi, including fungi with published genome sequences. The HMW genomic DNA can be prepared directly from a population of uncultured fungi in their natural habitat, environment, or biomass without the need of fungal isolation and cultivation.
- The techniques of HMW genomic DNA preparation for BAC cloning have been documented (Wu, C. C., et al, Encyclopedia of Molecular Cell Biology and Molecular Medicine Volume 3 (2nd Edition), Edited by Meyers R. A., Wiley-VCH Verlag GmbH: Weinheim, Germany 2004, pp 385-425; Zhang, M., et al., Nat. Protoc., 2012, 7: 467-478). In some configurations, HMW genomic DNA can include intact chromosomes or can be megabases in size.
- For preparation of HMW genomic DNA, fungal cells, such as, but without limitation, spores, germinated spores, protoplasts, or nuclei can be collected and directly embedded in low-melting agarose plugs. The low-melt agarose plugs can be from about 0.4% to about 1% in concentration and can have a final concentration of about 0.5%. HMW genomic DNA can be purified by treatment with lauryl sarcosine and proteinase K in 0.5 M EDTA, pH 9.0. HMW genomic DNA can be prepared by preparing fungal protoplasts (Bok, J. W. and Keller, N. P., Methods Mol. Biol., 2012, 944, 163-174) and then embedding the fungal protoplasts in low melt agarose plugs.
- HMW genomic DNA can be used to generate unbiased large insert recombinant DNA libraries to cover large intact SM gene clusters wherein one clone contains an intact SM gene cluster or pathway. The present teachings provide for preparation of liquid HMW genomic DNA by either electroelution or Gelase digestion of the agarose DNA plugs. The liquid HMW genomic DNA can then be mechanically sheared by hydroshearing, repeated pipetting, low-speed vortexing or a combination thereof. Conditions for a given fungal genome can be determined by running sheared HMW genomic DNA on a CHEFF gel with the size range of about 100 kb to about 300 kb.
- The E. coli-fungal shuttle BAC vectors or FAC (
FIG. 1 ) vectors disclosed herein (see Example 1) can be used for BAC/FAC library construction withaverage inserts 100 kb or larger. The present inventor has demonstrated that the large-insert FACs (at least 150 kb) can be shuttled into the heterologous A. nidulans host for stable maintenance and NP discovery (FIG. 3 , Bok, J. W., et al., BMC Genomics, 2015, 16, 343). - HMW genomic DNA was sheared as described in Methods. To 400 μl of sheared HMW genomic DNA (100˜300 kb), 5 μl of DNA end repairing enzyme mixture (Intact Genomics, St. Louis Mo.), 100 μl of 5× DNA end repairing buffer to a total of 500 μl. The sample is mixed well by gently pipetting with a wide-bore tip and the reaction is incubated at room temperature for 30 min. The DNA end repairing enzymes are heat killed by incubating the large DNA end repair reaction at 70° C. for 15 min. 20 μl each of 100 μM BstXI linker TOP and Bottom (10{circumflex over ( )}6˜10{circumflex over ( )}7-fold more molar rate excess linkers than the large DNA molecules), 61 μl of 10× T4 ligation buffer with ATP and 10 μl of large DNA T4 ligase (intactgenomics) are added immediately and then the reaction is mixed well by gently pipetting with a wide-bored tip. The linker ligation reaction is set at room temperature for 3-8 hours. The linker-ligated large DNA fragments are fractionated and excess BstXI linkers are removed by 1% agarose CHEFF gel electrophoresis at 0.5× TBE, 6V/cm, 90 s/90 s for 16 hours and 4V/cm, 5 s/5 s for additional 8 hours. Lambda DNA ladder marker (Intact Genomics) is used as a control to recover 100˜150, 150˜210, 210˜300 kb large DNA fractions as gel slices, and then the gel slices are placed into dialysis tubes and the DNA is electreluted, and then the purified linker-ligated large DNA fragments are dialyzed against 100 ml of ice-cold and autoclaved ultra-pure water at least 3 times, for one hour each. The cloning-ready BstXI-FAC vectors (20 ng/μl, Intact Genomics) are mixed with the gel-purified BstXI-linker ligated DNA (2˜3 ng/μl) at 1:3 molar rate, and the ligation reaction is set at 16° C. for overnight. For example, 200 ul large DNA (3 ng/μl) is mixed with 10 ul of the FAC vector (20 ng/μl), 60 μl of 5× T4 ligation buffer, 30 μl of BAC cloning T4 ligase (intactgenomics), ligation reaction is set at 16° C. for overnight, preferably 12˜18 hours.
- The large DNA fragments of the library are cloned into FAC vector(s) and serve as a screening library for covering the fungal SM gene clusters or pathways in E. coli. Preferably, the large-insert FAC library has
average insert size 100 kb or larger, therefore it is sufficient to contain at least one intact SM gene cluster in an individual FAC clone. Furthermore, the large-insert FAC library is unbiased and a FAC library with only 10×, or even 5× genome coverage can be enough to capture an entire set of intact SM gene clusters from a sequenced fungal genome or a fungal sample. Using the methods described herein, the inventor can capture a complete set of intact SM gene clusters with 4˜5 384-well plates of FAC clones (average about 100 kb, 4˜5× genome coverage) from all 6 fungi studied (Table 1; Bok, J. W., et al., BMC Genomics, 2015, 16, 343). - Because the FAC system is a shuttle BAC system, vectors of the present teachings can be in the BAC/fosmid library screening techniques known in the art. To identify intact SM gene cluster-containing FAC clones, sequence-based approaches can be used for FAC library screening such as PCR or colony hybridization (Zhang, H. B. and Wu, C. C., Plant Physiol. Biochem., 2001, 39, 1-15; Kang, H. S. and Brady, S. F., Angew. Chem. Int. Ed. Engl., 2013, 52, 11063-11067). One application of sequence-based approaches involves the design of DNA probes or primers which are derived from conserved regions of already known genes or protein families, for example but without limitation, pooled FAC DNAs from each arrayed library are screened using degenerate primers designed to amplify the conserved domains/regions of PKS or NRPS (Kang, H. S. and Brady, S. F., Angew. Chem. Int. Ed. Engl., 2013, 52, 11063-11067). Positive FAC clones can be recovered from libraries by PCR screening of the respective pools, followed by screening of their plates, columns, and rows from which they are identified. Another sequence based approach is to use high throughput next generation sequencing of pooled FAC libraries by plate-column-row with multiplex barcodes. This strategy will reduce sequence complexity from whole fungal genomes into FAC pool-level (plate-column-row), therefore enabling the complete assembly of pooled FAC clones (each 100 kb or larger). The intact SM gene clusters will be identified by annotation of completely sequenced and assembled FAC clones. The individual SM gene cluster-containing FAC clones will then be de-convoluted by barcodes and plate-column-row coordinates. The advantage of these sequence-based approaches is to identify SM gene clusters and their FACs from fungi without the precondition of genome sequence or even metagenomes of unculturable fungal community. In the present teachings, another sequence-based approach is used to sequence the FAC clone ends by the traditional Sanger sequencing method, then identify the entire set of intact SM gene cluster-containing FACs by aligning the FAC end sequences onto the fungal reference genome sequences. Similarly a next-generation sequence method may be used for this purpose with FAC DNA pooling and barcoding to reduce the sequencing cost.
- The parental strain RJW256 (pyrG89, pyroA4, Anku70::argB, ΔST::afpyrG, veA1) was obtained by a sexual cross between LO4641 (riboB2, pyroA4, ΔST::AfpyrG, ΔAN7909::afpyrG, Δnku70::argB, veA1) and RJW113.5 (ΔveA::argB, pyrG89). RJW256 was transformed with FAC plasmids to produce FAC recombinant strains. AST::AfpyrG indicates that the entire endogenous sterigmatocystin gene cluster was removed from A. nidulans.
- For antimicrobial activity tests, we used A. nidulans RDIT9.32, A. fumigatus 293, Candida albicans, Pseudomonas aeroginosa PAO1, Bacillus cereus U85, and Micrococcus luteus strains. All of the fungal and bacterial strains were maintained as frozen glycerol stocks at −80° C. Fungal strains were grown at 37° C. on glucose minimal medium (GMM, Bok, J. W. and Keller, N. P., Eukaryot. Cell, 2004, 3, 527-535) and bacterial strains were cultured on tryptic soy broth medium.
- A. nidulans Transformation and the Recovery of SM Cluster-Containing FACs
- A modified PEG-calcium based transformation method was applied to improve transformation. The described method (Bok, J. W. and Keller, N. P., Eukaryot. Cell, 2004, 3, 527-535) was modified as follows: 200 μL containing 107 A. nidulans RJW256 protoplasts mixed with 2 μg FAC DNA were gently placed over 200 μL of 30% PEG 4,000 with 50 mM CaCl2 in a 1.5 mL centrifuge tube. The centrifuge tube with protoplasts was incubated 30 min on ice. After centrifuging the incubated mixture for 5 min at 250×g, the solution was gently mixed using an autopipette. This mixture was then incubated for 10 minutes at room temperature before 1 mL of sorbitol-Tris-HCl-CaCl2 (STC: 1.2M sorbitol, 10 mM Tris-HCl, 10 mM CaCl2 pH 7.5) buffer was added and gently mixed into the solution. After transferring the mixture into a 13 mL tube, an additional 5 mL of STC was added into the tube and gently mixed. One mL of this final solution was distributed onto regeneration media to obtain transformants.
- A. nidulans FAC transformants were maintained on culture plates for three generations for phenotype and chemical screening. For FAC recovery, we prepared ˜0.3 mL of 106/mL protoplasts from A. nidulans FAC strains and FAC DNA was isolated by the common alkali lysis method, and resuspended in 10 μL of TE. One microliter of recovered DNA was re-transformed back into E. coli cells (BAC cells, Intact Genomics).
- Fungal DNA was extracted from lyophilized mycelia using previously described techniques (Bok, J. W. and Keller, N. P., Methods Mol. Biol., 2012, 944, 163-174) to perform PCR reaction.
- A disc-diffusion method (Bauer 1966) was used for antibiotic activity-guided screening. One plate of each A. nidulans FAC strain was inoculated on solid GMM and incubated for seven days at 37° C. Subsequently, the entire contents of the plates were collected and lyophilized for 48 hours. Samples were then pulverized with mortar and pestle prior to the addition of 10 mL of methanol. Air-dried methanol extracts were dissolved in 150 μL methanol for activity testing. Media preparation for antibacterial assays were performed as previously described (Bok, J. W. and Keller, N. P., Eukaryot. Cell, 2004, 3, 527-535). For antifungal assays, 106 spores mentioned in the section above were embedded in 5 mL soft GMM agar (0.75% agar) and overlaid on solid GMM. 10 μL out of the 150 μL methanol extract above was loaded on a 1 cm diameter paper disc for each assay. Assay plates were incubated for 24 to 48 hour at 37° C. and observed for antimicrobial activity.
- Five plates of A. nidulans FAC strain, for example and without limitation, AtFAC6J7 were inoculated on solid GMM and incubated for seven days at 37° C. Subsequently, the entire contents of the plates were collected and lyophilized for 48 hours. Samples were then pulverized with mortar and pestle prior to the addition of 10 mL of methanol. Air-dried methanol extracts were then further extracted with organic solvent (chloroform:methanol:ethylacetate=8:1:1). Organic extracts were evaporated to dryness and stored at −20° C. until analysis.
- Organic extracts obtained were resuspended in methanol to a final concentration of 2 μg/μL. For each analysis, 40 μg of sample was loaded onto a LUNA® C18 column (150 mm×2 mm; 3 μm particle size) (Phenomenex, Torrance, Calif.). Chromatography was performed using an AGILENT® 1150 LC system (Agilent, Santa Clara, Calif.) at a flow rate of 200 μL/min. The following gradient was employed (Buffer A: water with 0.1% formic acid, Buffer B: acetonitrile with 0.1% formic acid): time 0 min, 2% B; 35 min, 70% B; 54 min, 98% B. A 1:7 split was employed post-column, resulting in a flow rate of 25 μL/min being directed to the mass spectrometer. A Q-EXACTIVE™ mass spectrometer (Thermo Fisher Scientific, Waltham, Mass.) was used for MS analysis with the following settings: capillary temperature 275° C., sheath gas 4 (arbitrary units), spray voltage 4.2 kV. Full MS spectra were acquired at 35,000 resolution for the mass range m/z 200 to 1500 for all samples. Following each full MS scan, the top 5 most intense ions were selected for a dependent MS2 scan. MS2 was conducted using higher-energy collisional dissociation (HCD) with a normalized collision energy of 30%. Three biological replicates of AtFAC6J7 extracts were prepared and analyzed in technical duplicate, followed by the data workup described below.
- The SIEVE software suite (Thermo Fisher Scientific, Waltham, Mass.) was used for component detection and relative quantification of ions produced by electrospray during small molecule LC-HRMS. Component detection was performed using a mass tolerance of 10 part-per-million (ppm) and a retention time window of 2.5 min. A minimum intensity of 5×106 was selected as the threshold for defining a peak as a component. For each component, a selected ion chromatogram was created and the integrated intensity of the peak was calculated. Peak areas were normalized based on total ion current. To increase statistical power and confidence of the final analysis, the procedure adopted here involved a decoy approach to multiple hypothesis testing. Specifically, the replicate data AtFAC6J7 was subjected to a uniqueness filter against processed LC-HRMS data generated from a control group of strains containing empty vectors, as well as 13 other strains containing a variety of other FACs with unique genetic content. For dereplication, all components were initially searched against a targeted accurate mass database consisting of known fungal metabolites produced by A. nidulans using a mass tolerance of 3 ppm. A dozen of these known compounds were present at consistent levels in nearly all samples, and were monitored to rapidly identify highly perturbed systems. All components were also searched against a comprehensive accurate mass database consisting of over 13,000 known fungal secondary metabolites. This fungal database was prepared using Antibase (2011), Dictionary of Natural Products (2013), as well as additional fungal natural products found in the literature (Caboche et al. 2008; Andersen et al. 2013).
- The BstXI Linker overhang is not complementary to itself, nor is the BstXI-cut vector (above). Upon ligation of the linker-ligated large DNA fragments and vector, the preferred ligation reaction product can be a circle containing one vector joined to one large DNA fragment via a single adapter at each end. This molecule may be transformed into host cells to produce a clone.
- The present teachings including descriptions provided in the Examples that are not intended to limit the scope of any claim or aspect. Unless specifically presented in the past tense, an example can be a prophetic or an actual example. The following non-limiting examples are provided to further illustrate the present teachings. Those of skill in the art, in light of the present disclosure, will appreciate that many changes can be made in the specific embodiments that are disclosed and still obtain a like or similar result without departing from the spirit and scope of the present teachings.
- This example describes pFAC plasmid, a vector of the present teachings that maintains extra-chromosomes in A. nidulans.
- In the present teachings, a FAC vector (pFAC,
FIG. 1A , SEQ ID NO: 7) is a BAC-based shuttle vector that can shuttle large DNA between E. coli and A. nidulans hosts. Several features are required for maintaining the plasmid in E. coli, including two E. coli origins of replication: oriS and oriV. The first replication origin, oriS, is derived from a low-copy F plasmid for BAC-based large DNA cloning and library construction. The second replication origin, oriV, is an inducible high-copy replication origin oriV, which can produce higher yield of large inserts when grown in E. coli containing a TrfA gene under the control of an arabinose promoter when they are grown on arabinose containing media. pFAC also contains a chloramphenicol-resistance gene (cat) for plasmid selection. For cloning purposes, the plasmid contains a large DNA cloning site comprising pair of BstXI sites designed next to each other in oppose orientations. When digested with BstXI, this configuration produces a pair of identical BstXI overhangs, that are not self-complimentary, but are complimentary to unique BstXI linkers. Therefore, the digested vector will not religate itself, nor will the linkers concatermerize easily. Two I-SceI homing restriction sites were inserted flanking the BstXI cloning site in reverse orientations. These sites facilitate clean excision of the cloned large DNA fragment and exchange with pFACint cloning vector (see example 2). - pFAC also contains features required for use in A. nidulans. These include a third replication origin, AMA1, the autonomous maintenance in Aspergillus (AMA1, SEQ ID NO: 8). This sequence is required for maintaining large intact SM pathways as extra-chromosomal elements, or FACs. pFAC also contains a fungal selection marker gene, the orotidine-5′-phosphate decarboxylase gene (pyrG from A. parasiticus, SEQ ID NO: 9 & 10).
- This example describes pFACint, a FAC integration vector.
- FAC integration vector (pFACint,
FIG. 1B , SEQ ID NO: 11) is a BAC-based shuttle BAC vector that can shuttle large DNA between E. coli and A. nidulans hosts. Several features are required for maintaining the plasmid in E. coli, including two E. coli origins of replication: oriS and oriV. The first replication origin, oriS, is derived from a low-copy F plasmid for BAC-based large DNA cloning and library construction. The second replication origin, oriV, is an inducible high-copy replication origin oriV, which can produce higher yield of large inserts when grown in E. coli containing a TrfA gene under the control of an arabinose promoter when they are grown on arabinose containing media. pFACint carries kanamycin-resistance gene (kan) as a selection marker gene or cloning purposes, the plasmid contains a large DNA cloning site comprising pair of BstXI sites designed next to each other in oppose orientations. When digested with BstXI, this configuration produces a pair of identical BstXI overhangs, that are not self-complimentary, but are complimentary to unique BstXI linkers. Therefore, the digested vector will not religate itself, nor will the linkers concatermerize easily. Two I-SceI homing restriction sites were inserted flanking the BstXI cloning site in reverse orientations. These sites facilitate clean excision of the cloned large DNA fragment and exchange with pFAC cloning vector. The I-Sce-I homing restriction sites also facilitate clean excision of the large intact SM gene pathways from the genomic integration site of the heterologous host A. nidulans. - pFACint also contains features integrating the plasmid into the A. nidulans genome: 1,000-
bp 3′trpC (SEQ ID NO: 12) and 1,007-bp 5′trpC (SEQ ID NO: 13) homologous sequences, which were inserted flanking the I-Sce I restriction sites in the same orientations, thus enabling fungal site-specific integration of large pFACint clones into the A. nidulans trpC gene, which encodes a polypeptide homologous to polyketide. The plasmid also contains a fungal selection marker gene, the orotidine-5′-phosphate decarboxylase gene (pyrG, from A. parasiticus). - This example describes the vector pFACdual.
- pFACdual plasmid, which also substantially corresponds pFAC plasmid except that it includes an additional gene cassette: an attP site and a fungal codon-optimized phi31 integrase gene under the control of fungal inducible promoter, such as alcA(p). Therefore, the large DNA pFACdual clones are usually maintaining as FAC and also be able integrated into the fungal genome with an attB site whenever it is needed.
- pFACdual vector is a fungal dual-function vector (pFACdual,
FIG. 1C , SEQ ID NO: 14), and can act as both a fungal artificial chromosome and an inducible fungal genomic integration vector, or it can be used as an E. coli-A. nidulans shuttle BAC vector. pFACdual has similar features as pFAC (see Example 1), but pFAC dual has an additional gene cassette: an attP site and a fungal codon-optimized phi31 integrase gene (SEQ ID NO: 16 and SEQ ID NO: 17) under the control of the inducible alcA fungal promoter (alcA(p), SEQ ID NO: 15). Therefore, the large DNA pFACdual clones are usually maintained as a FAC but can be induced to integratd into the fungal genome with an attB site. - This example illustrates the preparation of high molecular weight A. wentii DNA.
- Aspergillus wentii strain DTO 134E9 was used as a proof of concept. Different fungal species/strain starting materials were compared to test for quality of high molecular weight (HMW) genomic DNA: spores, germinated spores, protoplasts, or nuclei obtained from protoplasts. The protoplast preparation method was performed as previously described (Bok, J. W. and Keller, N. P., Eukaryot. Cell, 2004, 3: 527-535). To isolate nuclei, protoplasts were lysed with 0.5% Triton X-100 in HMW DNA preparation buffer (0.5 M Sucrose, 80 mM KCl, 10 mM Tris, 10 mM EDTA, 1 mM sperm idine, 1 mM spermine, pH 9.4). The protoplasts in buffer were gently mixed, incubated on ice for 30 minutes, and the resulting nuclei pelleted at 1,800×g for 20 minutes. To prepare low melting agarose plugs of HMW DNA, the pellet (˜5×108)—of nuclei, protoplasts, germinated spores, or spores—was resuspended with the HMW DNA preparation buffer to a total volume of 0.6 mL, and an equal volume of 1% low melting agarose was then added to the buffer to a total volume of 1.2 mL at 45° C. This was sufficient to make 10 plugs (about 100 μL per plug) which solidified at 4° C. The plugs were then incubated at 50° C. for 48 hours in 1 mL lysis buffer/plug: 0.5 M EDTA, pH 9.0, 1% lauryl sarcosine, 1 mg/mL proteinase K. Finally, the plugs were extensively washed in 10-20 volumes of the following buffers for one hour for each wash: once with buffer 1 (0.5 M EDTA, pH 9.0-9.3 at 50° C.), once with buffer 2 (0.05 M EDTA, pH 8.0 on ice), three times with buffer 3 (ice cold TE plus 0.1 mM phenylmethyl sulfonyl fluoride (PMSF) on ice), three times with buffer 4 (ice cold TE on ice) and finally all plugs were stored in TE at 4° C. In order to estimate the size and yield of the extracted DNA, plugs were assessed using pulsed field gel electrophoresis (PFGE) (Bio-Rad CHEF Mapper, Hercules, Calif.). The final quality check conditions for the HMW genomic DNA were 6 V/cm, 10 sec to 1 min switch time for 12-16 hours at 14° C. by PFGE, along with appropriate HMW size markers (Zhang, M. et al., Nat. Protoc., 2012, 7, 467-478). The highest quality and quantity of HMW genomic DNA was obtained from the protoplast preparation (
FIG. 2A ).FIG. 2A shows a CHEF gel that contains A. wentii HMW genomic DNA ranging from greater than 50 kb but mainly Mb sizes of DNA fragments. - This example illustrates the construction of unbiased shuttle BAC library of A. wentii DNA.
- The HMW genomic DNA obtained from the protoplast preparation in Example 2 ranged from 50˜>1,000 kb (mainly megabase sized fragments). The HMW DNA from three plugs was end-repaired with the DNA end repair enzyme kit (Intact Genomics) in a total volume of 500 μL with 10 μL of the end repair enzymes which were then heat inactivated (70° C., 15 min). The resulting DNA was ligated with BstXI adaptors (10 μL of 100 μM each) and 10 μL ligase (2 U/μL, Intact Genomics) in a total volume of 700 μL. Gel-fractionated DNA fragments ranging from 100 to 200 kb were purified by PFGE. Purified large DNA fragments (about 100 μL 1-3 ng/μL) were ligated into the cloning ready BAC BstXI shuttle vector (pFAC) at 16° C. for ˜18 hours. Next, the ligated DNA mixture was electroporated into electroporation competent E. coli cells (BAC cells, Intact Genomics). Small-scale ligations and transformations (1 μL DNA per 20 μL cells) were used to judge the cloning efficiency. The insert sizes of about 50 BAC clones were determined and confirmed to include inserts of about 100 kb using CHEF gel electrophoresis and NotI digestion of random selected BAC clones in pFAC vector.
FIG. 2B illustrates that the average insert size was estimated at ˜100 kb (M, Lambda ladder Marker). Once the suitability of the ligated DNA was confirmed, large-scale ligations and transformations were conducted to achieve at least 7,680 clones for colony picking (20×384-well plates) for the unbiased shuttle BAC library. - This example illustrates BAC/FAC end sequencing, and select SM cluster-containing candidate FAC clones.
- BAC-end sequences of 1,536 clones from the unbiased Random Shear FAC library of A. wentii were completed by the Sanger BigDye sequencing method. The software Phred was used for base calling and sequence trimming. Vector masking was achieved using the DNAStar SeqMan Pro software package. The BAC end sequences were aligned against the A. wentii reference genome sequence by BLAST Assembled Genomes (NCBI). All 47 SM clusters-containing candidate FAC clones were successfully identified based on the FAC end sequence flanking one end of a SM cluster and the other FAC end sequence flanking the other end of the same SM cluster.
- This example illustrates construction of unbiased shuttle BAC library of A. wentii DNA and heterologous expression of SM clusters as FACs in A. nidulans.
- A. wentii was used as an example for shuttle BAC DNA library construction, and it has a fully sequenced genome containing 47 annotated SM gene clusters (Cerqueira, G. C., et al., Nucleic Acids Res., 2013, 42(Database issue), D705-D710). High molecular weight genomic DNA was prepared from A. wentii (see Example 4) and construction of the unbiased FAC library (see Example 5) resulted in ˜20× genome coverage of the A. wentii genome, or a total of 7,680 FAC clones with an average insert size of 100 kb (
FIG. 2A-B ). The FAC library was arrayed into 384-well plates and both ends of 1,536 FAC clones were sequenced. Sequence alignment of these end sequences with the A. wentii reference genome was used to identify SM-BAC clones or candidate FACs containing all 47 SM gene clusters (Table 1). In addition, at least 10 of 56 SM clusters of A. terreus are located near telomeres and some telomeric sequences are still not complete in the whole genome sequence database. These data illustrate that these methods successfully overcome the potential bias against telomeric sequences in conventional BAC library construction through the introduction of randomly sheared genomic DNA into the FAC vectors. - This example illustrates the validation of shuttle functions of FACs.
- To date hundreds of FACs (ranging from 70 to 150 kb in size) were used for heterologous expression and analysis through transformation into A. nidulans. To validate the shuttle function of FACs, we also extracted five of the 15 FAC DNAs from transformed A. nidulans strains and successfully transformed FAC DNA back into E. coli (
FIG. 3 ). A. nidulans was transformed with different FAC clones as determined by return of prototropy on medium without uracil and uridine. Forty or more colonies of E. coli each were then assessed from the recovery of the FACs inFIG. 3A-C respectively. The results show the recovery of FAC examples from all 3 A. nidulans transformants: AtFAC9O3 (˜100 kb), AtFAC9A23 (˜80 kb), and AtFAC7A10 (˜90 kb) respectively. The 2nd and 3rd (D) lane(s) on the left hand side of the gels is the control FAC used to transform A. nidulans. All recovered FACs were digested with NotI, there is no obvious large mutation observed. M, Lambda ladder Marker. This was the first demonstration of the capability of AMA1 in supporting autonomous replication (FAC) of large DNA constructs at least 150 kb in A. nidulans. The present inventor and his collaborators the first to demonstrate that the FAC system allows for extrachromosomal replication of at least 150 kb in A. nidulans (Bok, J. W., et al. BMC Genomics, 2015, 16, 343). - This example illustrates LC-HRMS linked FAC SM discovery.
- For the initial identification and structure elucidation of SM compounds through FACs, A. nidulans AtFAC9D19 strain samples were prepared as described in the Methods section. A. nidulans AtFAC9D19 was found to produce the insecticide compounds: alantrypinone, serantrypinone, alantrypinene B, alantryleunone. A. nidulans AtFAC6J7 strain was also selected for initial proof-of-concept experiments, as it contained a cluster highly homologous to the recently characterized hexadehydroastechrome cluster in A. fumigatus (Yin, W. B., et al., ACS Synth. Biol., 2013, 2, 629-634,). AtFAC6J7 contains seven out of the eight genes found in the corresponding A. fumigatus cluster. The gene not present in this A. terreus cluster, hasG, encodes for an FAD binding protein responsible for converting a prenyl to a methylbutadienyl side chain to produce hexadehydroastechrome from astechrome. AtFAC6J7 metabolites were identified by analyzing organic extracts of the A. nidulans AtFAC6J7 transformant and control A. nidulans using LC-HRMS. Following data acquisition, Sieve software was used for component detection and relative quantitation (see Methods). When comparing AtFAC6J7 extracts to control sample extracts (wild type and other FAC strains), a compound that was present only in the AtFAC6J7 extract was identified as terezine D by both accurate mass (0.3 part-per-million error) and tandem mass spectrometry (MS/MS or MS2). Terezine D is a stable intermediate of astechrome biosynthesis (Watanabe, T., et al., Bioorg. Med. Chem., 2009, 17, 94-111; Bok, J. W., et al. BMC Genomics, 2015, 16, 343).
- This example illustrates an antibiotic activity test against FAC clones.
- An antibiotic activity test was performed 14 FAC clones. Ten pl out of 150 μl methanol extract from FAC transformants cultured on GMM plate for 7 days at 37° C. were loaded on small disc (diameter: 1 cm) for antimicrobial activity test against Aspergillus spp., Candida albicans, Bacillus cereus, Micrococcus luteus and Pseudomonas aeruginosa. Antibiotic activity was observed against Bacillus cereus with two FAC extracts (Bok, J. W., et al. BMC Genomics, 2015, 16, 343).
- This example illustrates FAC recombineering and activating silent SM gene clusters.
- Red/ET tools were used to elucidate the biosynthesis of benzomalvins from A. terreus FAC AtFAC9J20. Two smaller-size constructs (33.372 kb AtFAC9J20Δ#1 and 68.988 kb AtFAC9J20Δ#2) were created from the FAC clone AtFAC9J20 (102.715 kb) using the NIH BAC recombineering tool with the Red/ET homologous recombination. We also deleted 5 genes (AtFAC9J20ΔMtase, AtFAC9J20ΔNRPS1, AtFAC9J20ΔNRPS2, AtFAC9J20ΔNRPS3, and AtFAC9J20ΔPKS) in the benzomalvin cluster to obtain 5 additional FAC mutation constructs that helped to precisely elucidate biosynthetic pathway benzomalvin efficiently and effectively.
- To activate a weakly expressed SM gene cluster in FAC AtFAC7O19, we have successfully inserted the fungal strong promoter gpdAp in front of the start codon ‘ATG’ of the transcription factor (TF) gene in this cluster. FAC recombineering was performed as a two step process. The inventor inserted the galK gene and selected Gal+ colonies on minimal media plus chloramphenicol and galactose and then replaced galK with the gpdA promoter by counter-selecting galK− colonies on minimal media plus chloramphicol, 2-deoxy-galactose, and glycerol. Eight out of eight trials produced FAC mutation constructs.
- Fusion PCR was performed (
FIG. 4A ) to combine the selectable marker (e.g. KanR or galK gene) and a promoter (gpdA(p) or any genetic element) as one PCR product for FAC recombineering. The strong fungal promoter gpdAp was inserted in front of the ATG start codon of SM cluster genes in FAC AtFAC7O19 with a kanamycin resistance gene. The Fusion PCR reactions are shown schematically inFIG. 4A (H1 and H2, homology sequences 1 and 2, respectively; cat, chloramphenicol acetyl transferase gene; FAC, origins of replication). For construction of the fusion PCR product of Kan gene and gpdA promoter, the primers used were: 38TF-Kan-leftendF (5′-TGGGACTTTGTCGCTCACGATTCGCCGAGTTGTATGGGCTGACCAGTGACcgacctgcagcctgttga-3′, SEQ ID NO: 1) and Kan-leftendR (5′-GGTGCCCCAAGCCTTGGATCCGTCGAGGCTGATCAGCGAgctc-3′, SEQ ID NO: 2); gpdA-rightendF (5′-TCGCTGATCAGCCTCGACGGATCCAAGGCTTGGGGCACCtgcgtt-3′, SEQ ID NO: 3) and 38TF-gpdA-rightendR (5′-TCCTCATGAATTAGATGGTTAGATGGACCTACCATCAGGATAGGTTCCATtgtgatgtctgctcaagcggg-3′, SEQ ID NO: 4). The result of the one-step targeting event is the insertion of constitutively active Kan-resistance gene next to gpdAp into a defined position on the FAC by selection on LB media with kanamycin and chloramphenicol for the maintenance of the engineered FAC. The fusion PCR insertions were confirmed with PCR followed by Notl restriction analysis of FAC DNA from 7 clones after the insertion of the kan-gpdAp selection cassettes, as shown in the gels inFIG. 4B . The first lane is unmodified FAC AtFAC7O19 DNA, which was included as a control. All tested clones show the same pattern, had the intended insertion but no obvious mutation on the pulse field gel. M, Lambda ladder Marker. The bacteria are now phenotypically Kan+. - An example of recombineering using the modified RED/ET tools includes the deletion of 5 genes of AtFAC9J20 individually with the galK selection cassette.
FIG. 5 shows the NotI restriction analysis of FAC miniprep DNA from 4 clones each were confirmed by PCR (M, Lambda ladder Marker). The second to last lane contains unmodified AtFAC9J20 DNA, which was included as a control. AtFAC9J20 contains 2 SM gene clusters. The five genes, all members of the same cluster, are 1.239-kb Mtase (dimethylallyltryptophan N-methyltransferase) gene, 3.334-kb NRPS1, 7.284-kb NRPS2, 7.815-kb NRPS3, and 7.741-kb PKS genes. Each set of 4 tested clones show the same pattern, and therefore had the intended deletion. No obvious mutations were detected by PCR, sequencing, or on the pulse field gel. - All engineered FACs were successfully transformed back into the A. nidulans host strain. Initially, heterologous expression of the intact FAC AtFAC9J20 identified a group of methylated NRPS products, which we successfully identified as belonging to benzomalvins family (benzomalvin A and benzomalvin E). Benzomalvin A is an indoleamine 2,3-dioxygenase (IDO) inhibitor with the potential of immune-therapy for cancer. With current FAC recombineering, we then observed a parallel 10,000-fold drop in signal of the NRPS products in the gene deletion mutants AtFAC9J20ΔNRPS1 and AtFAC9J20ΔNRPS2, which supports that these two NRPS are involved in the biosynthesis directly. We also observed accumulation of the expected biosynthetic precursors in our deletion mutants. In addition, accumulation of unmethylated intermediates in AtFAC9J20ΔMtase demonstrates identification of the methyl-transferase responsible for NRPS tailoring. In conclusion, we have established the biosynthesis of a known NRPS that has long eluded the field using the FAC technology and FAC deletants. These deletants not only allow us to see loss of their corresponding gene products, but also accumulation of biosynthetic precursors.
- All cited references are incorporated by reference, each in its entirety. Applicant reserves the right to challenge any conclusions presented by the authors of any reference.
Claims (16)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/409,586 US20190264216A1 (en) | 2016-01-25 | 2019-05-10 | Fungal artificial chromosomes, compositions, methods and uses therefor |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662286542P | 2016-01-25 | 2016-01-25 | |
US15/143,493 US10337019B2 (en) | 2016-01-25 | 2016-04-29 | Fungal artificial chromosomes, compositions, methods and uses therefor |
US16/409,586 US20190264216A1 (en) | 2016-01-25 | 2019-05-10 | Fungal artificial chromosomes, compositions, methods and uses therefor |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/143,493 Continuation US10337019B2 (en) | 2016-01-25 | 2016-04-29 | Fungal artificial chromosomes, compositions, methods and uses therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190264216A1 true US20190264216A1 (en) | 2019-08-29 |
Family
ID=59358906
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/143,493 Active 2036-06-04 US10337019B2 (en) | 2016-01-25 | 2016-04-29 | Fungal artificial chromosomes, compositions, methods and uses therefor |
US16/409,586 Abandoned US20190264216A1 (en) | 2016-01-25 | 2019-05-10 | Fungal artificial chromosomes, compositions, methods and uses therefor |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/143,493 Active 2036-06-04 US10337019B2 (en) | 2016-01-25 | 2016-04-29 | Fungal artificial chromosomes, compositions, methods and uses therefor |
Country Status (2)
Country | Link |
---|---|
US (2) | US10337019B2 (en) |
CN (1) | CN107574178B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230031689A (en) * | 2021-08-27 | 2023-03-07 | 한국화학연구원 | Composition for controlling plant diseases using Aspergillus montenegroi SFC20200425-M27 strain and method for manufacturing the same |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109385417A (en) * | 2017-08-03 | 2019-02-26 | 华东理工大学 | Internal DNA seamless integration method |
CN114075515B (en) * | 2020-08-12 | 2023-12-15 | 北京化工大学 | Cordyceps sinensis production genetic engineering bacteria and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030199038A1 (en) * | 2002-04-22 | 2003-10-23 | Novozymes Biotech, Inc. | Method for preparing polypeptide variants |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0742285A1 (en) * | 1995-05-10 | 1996-11-13 | Rijksuniversiteit Leiden | Method of isolating exonic gene segments of eukaryotic genes, exon trapping vectors for use therein |
US20110185456A1 (en) * | 1999-05-06 | 2011-07-28 | Nordine Cheikh | Annotatd plant genes |
GB0611484D0 (en) * | 2006-06-09 | 2006-07-19 | Sinvent As | Plasmid RK2-based broad-host-range cloning vector useful for transfer of metagenomic libraries to a variety of bacterial species |
-
2016
- 2016-04-29 US US15/143,493 patent/US10337019B2/en active Active
-
2017
- 2017-05-02 CN CN201710302226.0A patent/CN107574178B/en active Active
-
2019
- 2019-05-10 US US16/409,586 patent/US20190264216A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030199038A1 (en) * | 2002-04-22 | 2003-10-23 | Novozymes Biotech, Inc. | Method for preparing polypeptide variants |
Non-Patent Citations (4)
Title |
---|
Cullen et al. Gene, Vol.57, pages 21-26 (Year: 1987) * |
Lucigen CopyRight v2.0 BAC cloning kits flyer. (Year: 2015) * |
Ly et al (Journal of Microbiological Methods, 2011. Vol.86, pages 320-326) (Year: 2011) * |
Yamaguchi et al (PLoS ONE, 2011, Vol.6, no.2, e17267, pages 1-11). (Year: 2011) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230031689A (en) * | 2021-08-27 | 2023-03-07 | 한국화학연구원 | Composition for controlling plant diseases using Aspergillus montenegroi SFC20200425-M27 strain and method for manufacturing the same |
KR102633074B1 (en) | 2021-08-27 | 2024-02-05 | 한국화학연구원 | Composition for controlling plant diseases using Aspergillus montenegroi SFC20200425-M27 strain and method for manufacturing the same |
Also Published As
Publication number | Publication date |
---|---|
CN107574178B (en) | 2022-05-27 |
US10337019B2 (en) | 2019-07-02 |
CN107574178A (en) | 2018-01-12 |
US20170211077A1 (en) | 2017-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Efficient genome editing in Fusarium oxysporum based on CRISPR/Cas9 ribonucleoprotein complexes | |
Li et al. | Synthetic biology approaches for chromosomal integration of genes and pathways in industrial microbial systems | |
EP1356037B1 (en) | A library of a collection of cells | |
AU2002227882B2 (en) | Concatemers of differentially expressed multiple genes | |
US20190264216A1 (en) | Fungal artificial chromosomes, compositions, methods and uses therefor | |
RU2707542C1 (en) | METHOD OF PRODUCING A RECOMBINANT NUCLEASE CAS ESSENTIALLY FREE OF BACTERIAL ENDOTOXINS, THE PREPARATION OBTAINED BY THIS METHOD AND CONTAINING A KIT FOR USE IN A CRISPR/Cas SYSTEM | |
Jiménez et al. | Multiplex genome editing in Ashbya gossypii using CRISPR-Cpf1 | |
US20190144852A1 (en) | Combinatorial Metabolic Engineering Using a CRISPR System | |
CN104245938A (en) | Genetic manipulation and expression systems for pucciniomycotina and us tilaginom ycotina subphyla | |
CN118064425A (en) | Systems and methods for identifying and expressing gene clusters | |
Wang et al. | Recent advances in strategies for the cloning of natural product biosynthetic gene clusters | |
US20210207134A1 (en) | Reconstitution of dna-end repair pathway in prokaryotes | |
Zhong et al. | Base editing in Streptomyces with Cas9-deaminase fusions | |
Woodcraft et al. | The expanding CRISPR toolbox for natural product discovery and engineering in filamentous fungi | |
Yu et al. | Efficient genome editing in Claviceps purpurea using a CRISPR/Cas9 ribonucleoprotein method | |
Zhang et al. | CRISPR/dCas9-mediated gene silencing in two plant fungal pathogens | |
EP2935582B1 (en) | Compositions and methods for creating altered and improved cells and organisms | |
US11939571B2 (en) | Library-scale engineering of metabolic pathways | |
Madhavan et al. | Aspergillus spp., a versatile cell factory for enzymes and metabolites: Interventions through genome editing | |
US20150147774A1 (en) | Expression construct for yeast and a method of using the construct | |
Akers | Construction of CRISPR/Cas9 vectors for directed mutagenesis of Fusarium graminearum | |
Holm | Development and Implementation of Novel Genetic Tools for Investigation of FungalSecondary Metabolism | |
Arazoe et al. | Targeted genome editing using CRISPR/Cas9 system in fungi | |
US11787841B2 (en) | Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli | |
Jørgensen | Unraveling the secondary metabolism of the biotechnological important filamentous fungus Trichoderma reesei (Teleomorph Hypocrea jecorina) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: INTACT GENOMICS, INC., MISSOURI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WU, CHENGCANG CHARLES;REEL/FRAME:051422/0751 Effective date: 20171018 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |